Frances M. Ashcroft - Publications

Affiliations: 
University of Oxford, Oxford, United Kingdom 
Area:
ion channels

311/371 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2024 Vedovato N, Salguero MV, Greeley SAW, Yu CH, Philipson LH, Ashcroft FM. A loss-of-function mutation in KCNJ11 causing sulfonylurea-sensitive diabetes in early adult life. Diabetologia. PMID 38366195 DOI: 10.1007/s00125-024-06103-w  0.378
2023 Ashcroft FM. KATP Channels and the Metabolic Regulation of Insulin Secretion in Health and Disease: The 2022 Banting Medal for Scientific Achievement Award Lecture. Diabetes. 72: 693-702. PMID 37815796 DOI: 10.2337/dbi22-0030  0.374
2022 Pipatpolkai T, Usher SG, Vedovato N, Ashcroft FM, Stansfeld PJ. The dynamic interplay of PIP and ATP in the regulation of the K channel. The Journal of Physiology. PMID 36047384 DOI: 10.1113/JP283345  0.454
2021 Sachse G, Haythorne E, Hill T, Proks P, Joynson R, Terrón-Expósito R, Bentley L, Tucker SJ, Cox RD, Ashcroft FM. The KCNJ11-E23K Gene Variant Hastens Diabetes Progression by Impairing Glucose-Induced Insulin Secretion. Diabetes. PMID 33568422 DOI: 10.2337/db20-0691  0.597
2020 Pipatpolkai T, Corey RA, Proks P, Ashcroft FM, Stansfeld PJ. Evaluating inositol phospholipid interactions with inward rectifier potassium channels and characterising their role in disease. Communications Chemistry. 3: 147. PMID 36703430 DOI: 10.1038/s42004-020-00391-0  0.364
2020 Sachse G, Haythorne E, Proks P, Stewart M, Cater H, Ellard S, Davies B, Ashcroft FM. Phenotype of a transient neonatal diabetes point mutation (SUR1-R1183W) in mice. Wellcome Open Research. 5: 15. PMID 34368464 DOI: 10.12688/wellcomeopenres.15529.2  0.376
2020 Pipatpolkai T, Usher S, Stansfeld PJ, Ashcroft FM. New insights into K channel gene mutations and neonatal diabetes mellitus. Nature Reviews. Endocrinology. PMID 32376986 DOI: 10.1038/S41574-020-0351-Y  0.574
2020 Usher SG, Ashcroft FM, Puljung MC. Nucleotide inhibition of the pancreatic ATP-sensitive K channel explored with patch-clamp fluorometry. Elife. 9. PMID 31909710 DOI: 10.7554/Elife.52775  0.498
2020 Sachse G, Haythorne E, Proks P, Stewart M, Cater H, Ellard S, Davies B, Ashcroft FM. Phenotype of a transient neonatal diabetes point mutation (SUR1-R1183W) in mice Wellcome Open Research. 5: 15. DOI: 10.12688/wellcomeopenres.15529.1  0.356
2020 Usher S, Ashcroft FM, Puljung MC. Patch-Clamp Fluorometry Defines a Role for SUR1 in Nucleotide Inhibition of KATP Channels Biophysical Journal. 118: 190a. DOI: 10.1016/J.Bpj.2019.11.1154  0.506
2019 Haythorne E, Rohm M, van de Bunt M, Brereton MF, Tarasov AI, Blacker TS, Sachse G, Silva Dos Santos M, Terron Exposito R, Davis S, Baba O, Fischer R, Duchen MR, Rorsman P, MacRae JI, ... Ashcroft FM, et al. Diabetes causes marked inhibition of mitochondrial metabolism in pancreatic β-cells. Nature Communications. 10: 2474. PMID 31171772 DOI: 10.1038/S41467-019-10189-X  0.35
2019 Gommers LMM, Hill TG, Ashcroft FM, de Baaij JHF. Low extracellular magnesium does not impair glucose-stimulated insulin secretion. Plos One. 14: e0217925. PMID 31163064 DOI: 10.1371/Journal.Pone.0217925  0.358
2019 Puljung M, Vedovato N, Usher S, Ashcroft F. Activation mechanism of ATP-sensitive K channels explored with real-time nucleotide binding. Elife. 8. PMID 30789344 DOI: 10.7554/Elife.41103  0.494
2019 Vergari E, Knudsen JG, Ramracheya R, Salehi A, Zhang Q, Adam J, Asterholm IW, Benrick A, Briant LJB, Chibalina MV, Gribble FM, Hamilton A, Hastoy B, Reimann F, Rorsman NJG, ... ... Ashcroft FM, et al. Insulin inhibits glucagon release by SGLT2-induced stimulation of somatostatin secretion. Nature Communications. 10: 139. PMID 30635569 DOI: 10.1038/S41467-018-08193-8  0.551
2019 Usher SG, Ashcroft FM, Puljung MC. Author response: Nucleotide inhibition of the pancreatic ATP-sensitive K+ channel explored with patch-clamp fluorometry Elife. DOI: 10.7554/Elife.52775.Sa2  0.53
2019 Puljung M, Vedovato N, Usher S, Ashcroft F. Author response: Activation mechanism of ATP-sensitive K+ channels explored with real-time nucleotide binding Elife. DOI: 10.7554/Elife.41103.028  0.496
2019 Puljung MC, Usher S, Vedovato N, Ashcroft F. Nucleotide Modulation of KATP Channels Disentangled with FRET Biophysical Journal. 116: 108a-109a. DOI: 10.1016/J.Bpj.2018.11.619  0.479
2018 Knudsen JG, Hamilton A, Ramracheya R, Tarasov AI, Brereton M, Haythorne E, Chibalina MV, Spégel P, Mulder H, Zhang Q, Ashcroft FM, Adam J, Rorsman P. Dysregulation of Glucagon Secretion by Hyperglycemia-Induced Sodium-Dependent Reduction of ATP Production. Cell Metabolism. PMID 30415925 DOI: 10.1016/J.Cmet.2018.10.003  0.421
2018 Vedovato N, Rorsman O, Hennis K, Ashcroft FM, Proks P. Role of the C-terminus of SUR in the differential regulation of β-cell and cardiac K channels by MgADP and metabolism. The Journal of Physiology. PMID 30179258 DOI: 10.1113/Jp276708  0.543
2018 Misra S, Vedovato N, Cliff E, De Franco E, Hattersley AT, Ashcroft FM, Oliver NS. Permanent neonatal diabetes: combining sulfonylureas with insulin may be an effective treatment. Diabetic Medicine : a Journal of the British Diabetic Association. PMID 29896782 DOI: 10.1111/Dme.13758  0.318
2018 Proks P, Kramer H, Haythorne E, Ashcroft FM. Binding of sulphonylureas to plasma proteins - A KATP channel perspective. Plos One. 13: e0197634. PMID 29772022 DOI: 10.1371/Journal.Pone.0197634  0.445
2018 Rorsman P, Ashcroft FM. Pancreatic β-Cell Electrical Activity and Insulin Secretion: Of Mice and Men. Physiological Reviews. 98: 117-214. PMID 29212789 DOI: 10.1152/Physrev.00008.2017  0.371
2018 Usher SG, Vedovato N, Puljung MC, Ashcroft FM. Visualizing Adenine Nucleotide Regulation of the KATP Channel Biophysical Journal. 114: 25a-26a. DOI: 10.1016/J.Bpj.2017.11.185  0.422
2018 Vedovato N, Proks P, Rorsman OH, Hennis K, Ashcroft FM. Differential Metabolic and Nucleotide Sensitivity of Beta-Cell and Cardiac KATP Channels Biophysical Journal. 114: 203a-204a. DOI: 10.1016/J.Bpj.2017.11.1136  0.436
2017 Adam J, Ramracheya R, Chibalina MV, Ternette N, Hamilton A, Tarasov AI, Zhang Q, Rebelato E, Rorsman NJG, Martín-Del-Río R, Lewis A, Özkan G, Do HW, Spégel P, Saitoh K, ... ... Ashcroft FM, et al. Fumarate Hydratase Deletion in Pancreatic β Cells Leads to Progressive Diabetes. Cell Reports. 20: 3135-3148. PMID 28954230 DOI: 10.1016/J.Celrep.2017.08.093  0.365
2017 Ashcroft FM, Rohm M, Clark A, Brereton MF. Is Type 2 Diabetes a Glycogen Storage Disease of Pancreatic β Cells? Cell Metabolism. 26: 17-23. PMID 28683284 DOI: 10.1016/J.Cmet.2017.05.014  0.301
2017 Flanagan S, Dũng VC, Houghton J, De Franco E, Ngoc CTB, Damhuis A, Ashcroft F, Harries L, Ellard S. An ABCC8 nonsense mutation causing neonatal diabetes through altered transcript expression. Journal of Clinical Research in Pediatric Endocrinology. PMID 28663158 DOI: 10.4274/Jcrpe.4624  0.451
2017 Ashcroft FM, Puljung MC, Vedovato N. Neonatal Diabetes and the KATP Channel: From Mutation to Therapy. Trends in Endocrinology and Metabolism: Tem. PMID 28262438 DOI: 10.1016/J.Tem.2017.02.003  0.47
2017 Puljung MC, Vedovato N, Ashcroft FM. A Novel, Spectroscopic Window into Nucleotide Activation of KATP Channels Biophysical Journal. 112: 421a. DOI: 10.1016/J.Bpj.2016.11.2253  0.485
2016 Brereton MF, Rohm M, Shimomura K, Holland C, Tornovsky-Babeay S, Dadon D, Iberl M, Chibalina MV, Lee S, Glaser B, Dor Y, Rorsman P, Clark A, Ashcroft FM. Hyperglycaemia induces metabolic dysfunction and glycogen accumulation in pancreatic β-cells. Nature Communications. 7: 13496. PMID 27882918 DOI: 10.1038/Ncomms13496  0.338
2016 Dahan T, Ziv O, Horwitz E, Zemmour H, Lavi J, Swisa A, Leibowitz G, Ashcroft FM, Veld PI, Glaser B, Dor Y. Pancreatic Beta Cells Express the Fetal Islet Hormone Gastrin in Rodent and Human Diabetes. Diabetes. PMID 27864307 DOI: 10.2337/Db16-0641  0.352
2016 Proks P, Puljung MC, Vedovato N, Sachse G, Mulvaney R, Ashcroft FM. Correction to 'Running out of time: the decline of channel activity and nucleotide activation in adenosine triphosphate-sensitive K-channels'. Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences. 371. PMID 27481794 DOI: 10.1098/Rstb.2016.0330  0.503
2016 Proks P, Puljung MC, Vedovato N, Sachse G, Mulvaney R, Ashcroft FM. Running out of time: the decline of channel activity and nucleotide activation in adenosine triphosphate-sensitive K-channels. Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences. 371. PMID 27377720 DOI: 10.1098/Rstb.2015.0426  0.535
2016 Vedovato N, Cliff E, Proks P, Poovazhagi V, Flanagan SE, Ellard S, Hattersley AT, Ashcroft FM. Neonatal diabetes caused by a homozygous KCNJ11 mutation demonstrates that tiny changes in ATP sensitivity markedly affect diabetes risk. Diabetologia. PMID 27118464 DOI: 10.1007/S00125-016-3964-X  0.465
2016 Babiker T, Vedovato N, Patel K, Thomas N, Finn R, Männikkö R, Chakera AJ, Flanagan SE, Shepherd MH, Ellard S, Ashcroft FM, Hattersley AT. Successful transfer to sulfonylureas in KCNJ11 neonatal diabetes is determined by the mutation and duration of diabetes. Diabetologia. PMID 27033559 DOI: 10.1007/S00125-016-3921-8  0.388
2015 Vedovato N, Ashcroft FM, Puljung MC. The Nucleotide-Binding Sites of SUR1: A Mechanistic Model. Biophysical Journal. 109: 2452-60. PMID 26682803 DOI: 10.1016/J.Bpj.2015.10.026  0.541
2015 O'Connell SM, Proks P, Kramer H, Mattis KK, Sachse G, Joyce C, Houghton JA, Ellard S, Hattersley AT, Ashcroft FM, O'Riordan SM. The value of in vitro studies in a case of neonatal diabetes with a novel Kir6.2-W68G mutation. Clinical Case Reports. 3: 884-7. PMID 26509030 DOI: 10.1002/Ccr3.370  0.361
2015 Lahmann C, Kramer HB, Ashcroft FM. Systemic Administration of Glibenclamide Fails to Achieve Therapeutic Levels in the Brain and Cerebrospinal Fluid of Rodents. Plos One. 10: e0134476. PMID 26225433 DOI: 10.1371/Journal.Pone.0134476  0.371
2015 Cantley J, Ashcroft FM. Q&A: insulin secretion and type 2 diabetes: why do β-cells fail? Bmc Biology. 13: 33. PMID 25982967 DOI: 10.1186/S12915-015-0140-6  0.332
2014 Proks P, de Wet H, Ashcroft FM. Sulfonylureas suppress the stimulatory action of Mg-nucleotides on Kir6.2/SUR1 but not Kir6.2/SUR2A KATP channels: a mechanistic study. The Journal of General Physiology. 144: 469-86. PMID 25348414 DOI: 10.1085/Jgp.201411222  0.589
2014 Ashcroft FM. Ion channels in lymphocytes. Immunology Today. 5: 232-3. PMID 25290144 DOI: 10.1016/0167-5699(84)90095-1  0.404
2014 Zhang Q, Chibalina MV, Bengtsson M, Groschner LN, Ramracheya R, Rorsman NJ, Leiss V, Nassar MA, Welling A, Gribble FM, Reimann F, Hofmann F, Wood JN, Ashcroft FM, Rorsman P. Na+ current properties in islet α- and β-cells reflect cell-specific Scn3a and Scn9a expression. The Journal of Physiology. 592: 4677-96. PMID 25172946 DOI: 10.1113/Jphysiol.2014.274209  0.573
2014 Brereton MF, Iberl M, Shimomura K, Zhang Q, Adriaenssens AE, Proks P, Spiliotis II, Dace W, Mattis KK, Ramracheya R, Gribble FM, Reimann F, Clark A, Rorsman P, Ashcroft FM. Reversible changes in pancreatic islet structure and function produced by elevated blood glucose. Nature Communications. 5: 4639. PMID 25145789 DOI: 10.1038/Ncomms5639  0.606
2014 Lahmann C, Clark RH, Iberl M, Ashcroft FM. A mutation causing increased KATP channel activity leads to reduced anxiety in mice. Physiology & Behavior. 129: 79-84. PMID 24582665 DOI: 10.1016/J.Physbeh.2014.02.031  0.372
2014 Tornovsky-Babeay S, Dadon D, Ziv O, Tzipilevich E, Kadosh T, Schyr-Ben Haroush R, Hija A, Stolovich-Rain M, Furth-Lavi J, Granot Z, Porat S, Philipson LH, Herold KC, Bhatti TR, Stanley C, ... Ashcroft FM, et al. Type 2 diabetes and congenital hyperinsulinism cause DNA double-strand breaks and p53 activity in β cells. Cell Metabolism. 19: 109-21. PMID 24332968 DOI: 10.1016/J.Cmet.2013.11.007  0.405
2013 Brereton MF, Ashcroft FM. Mouse Models of β-cell K Channel Dysfunction. Drug Discovery Today. Disease Models. 10: e101-e109. PMID 29643927 DOI: 10.1016/J.Ddmod.2013.02.001  0.545
2013 Zhang Q, Ramracheya R, Lahmann C, Tarasov A, Bengtsson M, Braha O, Braun M, Brereton M, Collins S, Galvanovskis J, Gonzalez A, Groschner LN, Rorsman NJ, Salehi A, Travers ME, ... ... Ashcroft FM, et al. Role of KATP channels in glucose-regulated glucagon secretion and impaired counterregulation in type 2 diabetes. Cell Metabolism. 18: 871-82. PMID 24315372 DOI: 10.1016/J.Cmet.2013.10.014  0.67
2013 Ashcroft FM, Rorsman P. K(ATP) channels and islet hormone secretion: new insights and controversies. Nature Reviews. Endocrinology. 9: 660-9. PMID 24042324 DOI: 10.1038/Nrendo.2013.166  0.578
2013 Shimomura K, Tusa M, Iberl M, Brereton MF, Kaizik S, Proks P, Lahmann C, Yaluri N, Modi S, Huopio H, Ustinov J, Otonkoski T, Laakso M, Ashcroft FM. A mouse model of human hyperinsulinism produced by the E1506K mutation in the sulphonylurea receptor SUR1. Diabetes. 62: 3797-806. PMID 23903354 DOI: 10.2337/Db12-1611  0.436
2013 Proks P, de Wet H, Ashcroft FM. Molecular mechanism of sulphonylurea block of K(ATP) channels carrying mutations that impair ATP inhibition and cause neonatal diabetes. Diabetes. 62: 3909-19. PMID 23835339 DOI: 10.2337/Db13-0531  0.552
2013 McTaggart JS, Jenkinson N, Brittain JS, Greeley SA, Hattersley AT, Ashcroft FM. Gain-of-function mutations in the K(ATP) channel (KCNJ11) impair coordinated hand-eye tracking. Plos One. 8: e62646. PMID 23626843 DOI: 10.1371/Journal.Pone.0062646  0.335
2013 Fendler W, Pietrzak I, Brereton MF, Lahmann C, Gadzicki M, Bienkiewicz M, Drozdz I, Borowiec M, Malecki MT, Ashcroft FM, Mlynarski WM. Switching to sulphonylureas in children with iDEND syndrome caused by KCNJ11 mutations results in improved cerebellar perfusion. Diabetes Care. 36: 2311-6. PMID 23462667 DOI: 10.2337/Dc12-2166  0.386
2013 Loh NY, Bentley L, Dimke H, Verkaart S, Tammaro P, Gorvin CM, Stechman MJ, Ahmad BN, Hannan FM, Piret SE, Evans H, Bellantuono I, Hough TA, Fraser WD, Hoenderop JG, ... Ashcroft FM, et al. Autosomal dominant hypercalciuria in a mouse model due to a mutation of the epithelial calcium channel, TRPV5. Plos One. 8: e55412. PMID 23383183 DOI: 10.1371/Journal.Pone.0055412  0.347
2013 Fotinou C, Aittoniemi J, de Wet H, Polidori A, Pucci B, Sansom MS, Vénien-Bryan C, Ashcroft FM. Tetrameric structure of SUR2B revealed by electron microscopy of oriented single particles. The Febs Journal. 280: 1051-63. PMID 23253866 DOI: 10.1111/Febs.12097  0.404
2013 Brereton MF, Ashcroft FM. Mouse models of β-cell KATP channel dysfunction Drug Discovery Today: Disease Models. 10: e101-e109. DOI: 10.1016/j.ddmod.2013.02.001  0.305
2012 de Wet H, Shimomura K, Aittoniemi J, Ahmad N, Lafond M, Sansom MS, Ashcroft FM. A universally conserved residue in the SUR1 subunit of the KATP channel is essential for translating nucleotide binding at SUR1 into channel opening. The Journal of Physiology. 590: 5025-36. PMID 22802590 DOI: 10.1113/Jphysiol.2012.236075  0.523
2012 Ashcroft FM, Rorsman P. Diabetes mellitus and the β cell: the last ten years. Cell. 148: 1160-71. PMID 22424227 DOI: 10.1016/J.Cell.2012.02.010  0.303
2012 Clark R, Männikkö R, Stuckey DJ, Iberl M, Clarke K, Ashcroft FM. Mice expressing a human K(ATP) channel mutation have altered channel ATP sensitivity but no cardiac abnormalities. Diabetologia. 55: 1195-204. PMID 22252471 DOI: 10.1007/S00125-011-2428-6  0.511
2012 Cheffings CM, Pantoja O, Ashcroft FM, Smith JA. Malate transport and vacuolar ion channels in CAM plants. Journal of Experimental Botany. 623-31. PMID 21245236 DOI: 10.1093/Jxb/48.Special_Issue.623  0.381
2011 Männikkö R, Flanagan SE, Sim X, Segal D, Hussain K, Ellard S, Hattersley AT, Ashcroft FM. Mutations of the same conserved glutamate residue in NBD2 of the sulfonylurea receptor 1 subunit of the KATP channel can result in either hyperinsulinism or neonatal diabetes. Diabetes. 60: 1813-22. PMID 21617188 DOI: 10.2337/Db10-1583  0.549
2011 Meadows NA, Saxty B, Albury MS, Kettleborough CA, Ashcroft FM, Moore AL, Cox RD. A high-throughput assay for modulators of NNT activity in permeabilized yeast cells. Journal of Biomolecular Screening. 16: 734-43. PMID 21602486 DOI: 10.1177/1087057111408088  0.362
2011 Männikkö R, Stansfeld PJ, Ashcroft AS, Hattersley AT, Sansom MS, Ellard S, Ashcroft FM. A conserved tryptophan at the membrane-water interface acts as a gatekeeper for Kir6.2/SUR1 channels and causes neonatal diabetes when mutated. The Journal of Physiology. 589: 3071-83. PMID 21540348 DOI: 10.1113/Jphysiol.2011.209700  0.542
2011 Porat S, Weinberg-Corem N, Tornovsky-Babaey S, Schyr-Ben-Haroush R, Hija A, Stolovich-Rain M, Dadon D, Granot Z, Ben-Hur V, White P, Girard CA, Karni R, Kaestner KH, Ashcroft FM, Magnuson MA, et al. Control of pancreatic β cell regeneration by glucose metabolism. Cell Metabolism. 13: 440-9. PMID 21459328 DOI: 10.1016/J.Cmet.2011.02.012  0.389
2011 Hoppa MB, Collins S, Ramracheya R, Hodson L, Amisten S, Zhang Q, Johnson P, Ashcroft FM, Rorsman P. Chronic palmitate exposure inhibits insulin secretion by dissociation of Ca2+ channels from secretory granules (Cell Metabolism) Cell Metabolism. 13: 487. DOI: 10.1016/j.cmet.2011.03.002  0.307
2010 Proks P, de Wet H, Ashcroft FM. Activation of the K(ATP) channel by Mg-nucleotide interaction with SUR1. The Journal of General Physiology. 136: 389-405. PMID 20876358 DOI: 10.1085/Jgp.201010475  0.572
2010 Hugill A, Shimomura K, Ashcroft FM, Cox RD. A mutation in KCNJ11 causing human hyperinsulinism (Y12X) results in a glucose-intolerant phenotype in the mouse. Diabetologia. 53: 2352-6. PMID 20694718 DOI: 10.1007/S00125-010-1866-X  0.42
2010 Clark RH, McTaggart JS, Webster R, Mannikko R, Iberl M, Sim XL, Rorsman P, Glitsch M, Beeson D, Ashcroft FM. Muscle dysfunction caused by a KATP channel mutation in neonatal diabetes is neuronal in origin. Science (New York, N.Y.). 329: 458-61. PMID 20595581 DOI: 10.1126/Science.1186146  0.476
2010 de Wet H, Fotinou C, Amad N, Dreger M, Ashcroft FM. The ATPase activities of sulfonylurea receptor 2A and sulfonylurea receptor 2B are influenced by the C-terminal 42 amino acids. The Febs Journal. 277: 2654-62. PMID 20553499 DOI: 10.1111/J.1742-464X.2010.07675.X  0.479
2010 Shimomura K, de Nanclares GP, Foutinou C, Caimari M, Castaño L, Ashcroft FM. The first clinical case of a mutation at residue K185 of Kir6.2 (KCNJ11): a major ATP-binding residue. Diabetic Medicine : a Journal of the British Diabetic Association. 27: 225-9. PMID 20546268 DOI: 10.1111/J.1464-5491.2009.02901.X  0.569
2010 McTaggart JS, Clark RH, Ashcroft FM. The role of the KATP channel in glucose homeostasis in health and disease: more than meets the islet. The Journal of Physiology. 588: 3201-9. PMID 20519313 DOI: 10.1113/Jphysiol.2010.191767  0.528
2010 Aittoniemi J, de Wet H, Ashcroft FM, Sansom MS. Asymmetric switching in a homodimeric ABC transporter: a simulation study. Plos Computational Biology. 6: e1000762. PMID 20454684 DOI: 10.1371/Journal.Pcbi.1000762  0.325
2010 Ashcroft FM. New uses for old drugs: neonatal diabetes and sulphonylureas. Cell Metabolism. 11: 179-81. PMID 20197050 DOI: 10.1016/J.Cmet.2010.02.004  0.417
2010 Männikkö R, Jefferies C, Flanagan SE, Hattersley A, Ellard S, Ashcroft FM. Interaction between mutations in the slide helix of Kir6.2 associated with neonatal diabetes and neurological symptoms. Human Molecular Genetics. 19: 963-72. PMID 20022885 DOI: 10.1093/Hmg/Ddp554  0.559
2010 Aittoniemi J, Ashcroft FM, Sansom MS. Investigation of Protonation Effects on ATP Binding in ABC Transporters Biophysical Journal. 98: 759a. DOI: 10.1016/J.Bpj.2009.12.4169  0.305
2010 Stansfeld PJ, Hopkinson RJ, Ashcroft FM, Sansom MS. Investigating the PIP2 Binding Site in Kir Channels Via Multi-Scale Biomolecular Simulations Biophysical Journal. 98: 698a. DOI: 10.1016/J.Bpj.2009.12.3833  0.469
2009 Shimomura K, Flanagan SE, Zadek B, Lethby M, Zubcevic L, Girard CA, Petz O, Mannikko R, Kapoor RR, Hussain K, Skae M, Clayton P, Hattersley A, Ellard S, Ashcroft FM. Adjacent mutations in the gating loop of Kir6.2 produce neonatal diabetes and hyperinsulinism. Embo Molecular Medicine. 1: 166-77. PMID 20049716 DOI: 10.1002/Emmm.200900018  0.826
2009 Hoppa MB, Collins S, Ramracheya R, Hodson L, Amisten S, Zhang Q, Johnson P, Ashcroft FM, Rorsman P. Chronic palmitate exposure inhibits insulin secretion by dissociation of Ca(2+) channels from secretory granules. Cell Metabolism. 10: 455-65. PMID 19945403 DOI: 10.1016/J.Cmet.2009.09.011  0.359
2009 Stansfeld PJ, Hopkinson R, Ashcroft FM, Sansom MS. PIP(2)-binding site in Kir channels: definition by multiscale biomolecular simulations. Biochemistry. 48: 10926-33. PMID 19839652 DOI: 10.1021/Bi9013193  0.454
2009 Shimomura K, Galvanovskis J, Goldsworthy M, Hugill A, Kaizak S, Lee A, Meadows N, Quwailid MM, Rydström J, Teboul L, Ashcroft F, Cox RD. Insulin secretion from beta-cells is affected by deletion of nicotinamide nucleotide transhydrogenase. Methods in Enzymology. 457: 451-80. PMID 19426883 DOI: 10.1016/S0076-6879(09)05025-3  0.362
2009 Ashcroft FM, Zubcevic L. Retraction for Ma et al. "Glucose regulates the effects of leptin on hypothalamic POMC neurons". Proceedings of the National Academy of Sciences of the United States of America. 106: 7263. PMID 19380749 DOI: 10.1073/Pnas.0902342106  0.709
2009 Craig TJ, Shimomura K, Holl RW, Flanagan SE, Ellard S, Ashcroft FM. An in-frame deletion in Kir6.2 (KCNJ11) causing neonatal diabetes reveals a site of interaction between Kir6.2 and SUR1. The Journal of Clinical Endocrinology and Metabolism. 94: 2551-7. PMID 19351728 DOI: 10.1210/Mend.23.6.9997  0.466
2009 Tammaro P, Ashcroft FM. A cytosolic factor that inhibits KATP channels expressed in Xenopus oocytes by impairing Mg-nucleotide activation by SUR1. The Journal of Physiology. 587: 1649-56. PMID 19237428 DOI: 10.1113/Jphysiol.2008.165126  0.573
2009 Girard CA, Wunderlich FT, Shimomura K, Collins S, Kaizik S, Proks P, Abdulkader F, Clark A, Ball V, Zubcevic L, Bentley L, Clark R, Church C, Hugill A, Galvanovskis J, ... ... Ashcroft FM, et al. Expression of an activating mutation in the gene encoding the KATP channel subunit Kir6.2 in mouse pancreatic beta cells recapitulates neonatal diabetes. The Journal of Clinical Investigation. 119: 80-90. PMID 19065048 DOI: 10.1172/Jci35772  0.79
2009 Aittoniemi J, Fotinou C, Craig TJ, de Wet H, Proks P, Ashcroft FM. Review. SUR1: a unique ATP-binding cassette protein that functions as an ion channel regulator. Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences. 364: 257-67. PMID 18990670 DOI: 10.1098/Rstb.2008.0142  0.519
2009 Proks P, Ashcroft FM. Modeling K(ATP) channel gating and its regulation. Progress in Biophysics and Molecular Biology. 99: 7-19. PMID 18983870 DOI: 10.1016/J.Pbiomolbio.2008.10.002  0.595
2009 Ashcroft F, Gadsby D, Miller C. Introduction. The blurred boundary between channels and transporters: We dedicate this volume to the memory of Peter Läuger, a pioneer of the link between channels and pumps Philosophical Transactions of the Royal Society B: Biological Sciences. 364: 145-147. PMID 18957372 DOI: 10.1098/Rstb.2008.0245  0.376
2009 Hoppa MB, Collins S, Ramracheya R, Johnson P, Ashcroft FM, Rorsman P. Chronic Palmitate Exposure Inhibits Insulin Secretion By Dissociation of Ca2+-Channels From Secretory Vesicles Biophysical Journal. 96: 103a. DOI: 10.1016/J.Bpj.2008.12.442  0.357
2009 Sobek JA, Contera SA, Trigueros S, Fotinou C, Ashcroft FM, Ryan J. High Resolution AFM of KcsA Structure and Clustering in a Lipid Bilayer Biophysical Journal. 96: 370a. DOI: 10.1016/J.Bpj.2008.12.1995  0.362
2008 Zehetner J, Danzer C, Collins S, Eckhardt K, Gerber PA, Ballschmieter P, Galvanovskis J, Shimomura K, Ashcroft FM, Thorens B, Rorsman P, Krek W. PVHL is a regulator of glucose metabolism and insulin secretion in pancreatic beta cells. Genes & Development. 22: 3135-46. PMID 19056893 DOI: 10.1101/Gad.496908  0.357
2008 Ma X, Zubcevic L, Ashcroft FM. Glucose regulates the effects of leptin on hypothalamic POMC neurons. Proceedings of the National Academy of Sciences of the United States of America. 105: 9811-6. PMID 18599453 DOI: 10.1073/Pnas.0800952105  0.729
2008 Craig TJ, Ashcroft FM, Proks P. How ATP inhibits the open K(ATP) channel. The Journal of General Physiology. 132: 131-44. PMID 18591420 DOI: 10.1085/Jgp.200709874  0.536
2008 Staník J, Lethby M, Flanagan SE, Gasperíková D, Milosovicová B, Lever M, Bullman H, Zubcevic L, Hattersley AT, Ellard S, Ashcroft FM, Klimes I. Coincidence of a novel KCNJ11 missense variant R365H with a paternally inherited 6q24 duplication in a patient with transient neonatal diabetes. Diabetes Care. 31: 1736-7. PMID 18556340 DOI: 10.2337/Dc08-0549  0.727
2008 D'Amato E, Tammaro P, Craig TJ, Tosi A, Giorgetti R, Lorini R, Ashcroft FM. Variable phenotypic spectrum of diabetes mellitus in a family carrying a novel KCNJ11 gene mutation. Diabetic Medicine : a Journal of the British Diabetic Association. 25: 651-6. PMID 18544102 DOI: 10.1111/J.1464-5491.2008.02443.X  0.449
2008 de Wet H, Proks P, Lafond M, Aittoniemi J, Sansom MS, Flanagan SE, Pearson ER, Hattersley AT, Ashcroft FM. A mutation (R826W) in nucleotide-binding domain 1 of ABCC8 reduces ATPase activity and causes transient neonatal diabetes. Embo Reports. 9: 648-54. PMID 18497752 DOI: 10.1038/Embor.2008.71  0.539
2008 Goldsworthy M, Hugill A, Freeman H, Horner E, Shimomura K, Bogani D, Pieles G, Mijat V, Arkell R, Bhattacharya S, Ashcroft FM, Cox RD. Role of the transcription factor sox4 in insulin secretion and impaired glucose tolerance. Diabetes. 57: 2234-44. PMID 18477811 DOI: 10.2337/Db07-0337  0.421
2008 Tammaro P, Flanagan SE, Zadek B, Srinivasan S, Woodhead H, Hameed S, Klimes I, Hattersley AT, Ellard S, Ashcroft FM. A Kir6.2 mutation causing severe functional effects in vitro produces neonatal diabetes without the expected neurological complications. Diabetologia. 51: 802-10. PMID 18335204 DOI: 10.1007/S00125-008-0923-1  0.531
2008 Shield JP, Flanagan SE, Mackay DJ, Harries LW, Proks P, Girard C, Ashcroft FM, Temple IK, Ellard S. Mosaic paternal uniparental isodisomy and an ABCC8 gene mutation in a patient with permanent neonatal diabetes and hemihypertrophy. Diabetes. 57: 255-8. PMID 17942821 DOI: 10.2337/Db07-0999  0.342
2008 Tricarico D, Mele A, Liss B, Ashcroft FM, Lundquist AL, Desai RR, George AL, Conte Camerino D. Reduced expression of Kir6.2/SUR2A subunits explains KATP deficiency in K+-depleted rats. Neuromuscular Disorders : Nmd. 18: 74-80. PMID 17825556 DOI: 10.1016/J.Nmd.2007.07.009  0.48
2008 Proks P, Ashcroft FM. ATP-sensitive potassium channels in health and disease Pancreatic Beta Cell in Health and Disease. 431-450. DOI: 10.1007/978-4-431-75452-7_20  0.348
2007 de Wet H, Rees MG, Shimomura K, Aittoniemi J, Patch AM, Flanagan SE, Ellard S, Hattersley AT, Sansom MS, Ashcroft FM. Increased ATPase activity produced by mutations at arginine-1380 in nucleotide-binding domain 2 of ABCC8 causes neonatal diabetes. Proceedings of the National Academy of Sciences of the United States of America. 104: 18988-92. PMID 18025464 DOI: 10.1073/Pnas.0707428104  0.555
2007 Mlynarski W, Tarasov AI, Gach A, Girard CA, Pietrzak I, Zubcevic L, Kusmierek J, Klupa T, Malecki MT, Ashcroft FM. Sulfonylurea improves CNS function in a case of intermediate DEND syndrome caused by a mutation in KCNJ11. Nature Clinical Practice. Neurology. 3: 640-5. PMID 17982434 DOI: 10.1038/Ncpneuro0640  0.798
2007 Jarosławski S, Zadek B, Ashcroft F, Vénien-Bryan C, Scheuring S. Direct Visualization of KirBac3.1 Potassium Channel Gating by Atomic Force Microscopy Journal of Molecular Biology. 374: 500-505. PMID 17936299 DOI: 10.1016/J.Jmb.2007.09.043  0.484
2007 Tarasov AI, Girard CA, Larkin B, Tammaro P, Flanagan SE, Ellard S, Ashcroft FM. Functional analysis of two Kir6.2 (KCNJ11) mutations, K170T and E322K, causing neonatal diabetes. Diabetes, Obesity & Metabolism. 9: 46-55. PMID 17919178 DOI: 10.1111/J.1463-1326.2007.00777.X  0.562
2007 Tammaro P, Ashcroft FM. A mutation in the ATP-binding site of the Kir6.2 subunit of the KATP channel alters coupling with the SUR2A subunit. The Journal of Physiology. 584: 743-53. PMID 17855752 DOI: 10.1113/Jphysiol.2007.143149  0.565
2007 Haider S, Tarasov AI, Craig TJ, Sansom MS, Ashcroft FM. Identification of the PIP2-binding site on Kir6.2 by molecular modelling and functional analysis. The Embo Journal. 26: 3749-59. PMID 17673911 DOI: 10.1038/Sj.Emboj.7601809  0.531
2007 Ellard S, Flanagan SE, Girard CA, Patch AM, Harries LW, Parrish A, Edghill EL, Mackay DJ, Proks P, Shimomura K, Haberland H, Carson DJ, Shield JP, Hattersley AT, Ashcroft FM. Permanent neonatal diabetes caused by dominant, recessive, or compound heterozygous SUR1 mutations with opposite functional effects. American Journal of Human Genetics. 81: 375-82. PMID 17668386 DOI: 10.1086/519174  0.4
2007 Shimomura K, Hörster F, de Wet H, Flanagan SE, Ellard S, Hattersley AT, Wolf NI, Ashcroft F, Ebinger F. A novel mutation causing DEND syndrome: a treatable channelopathy of pancreas and brain. Neurology. 69: 1342-9. PMID 17652641 DOI: 10.1212/01.Wnl.0000268488.51776.53  0.475
2007 Ashcroft FM. The Walter B. Cannon Physiology in Perspective Lecture, 2007. ATP-sensitive K+ channels and disease: from molecule to malady. American Journal of Physiology. Endocrinology and Metabolism. 293: E880-9. PMID 17652156 DOI: 10.1152/Ajpendo.00348.2007  0.584
2007 Ma X, Bruning J, Ashcroft FM. Glucagon-like peptide 1 stimulates hypothalamic proopiomelanocortin neurons. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 27: 7125-9. PMID 17611265 DOI: 10.1523/Jneurosci.1025-07.2007  0.35
2007 Proks P, Shimomura K, Craig TJ, Girard CA, Ashcroft FM. Mechanism of action of a sulphonylurea receptor SUR1 mutation (F132L) that causes DEND syndrome. Human Molecular Genetics. 16: 2011-9. PMID 17584766 DOI: 10.1093/Hmg/Ddm149  0.542
2007 de Wet H, Mikhailov MV, Fotinou C, Dreger M, Craig TJ, Vénien-Bryan C, Ashcroft FM. Studies of the ATPase activity of the ABC protein SUR1. The Febs Journal. 274: 3532-44. PMID 17561960 DOI: 10.1111/J.1742-4658.2007.05879.X  0.394
2007 Könner AC, Janoschek R, Plum L, Jordan SD, Rother E, Ma X, Xu C, Enriori P, Hampel B, Barsh GS, Kahn CR, Cowley MA, Ashcroft FM, Brüning JC. Insulin action in AgRP-expressing neurons is required for suppression of hepatic glucose production. Cell Metabolism. 5: 438-49. PMID 17550779 DOI: 10.1016/J.Cmet.2007.05.004  0.327
2007 Medina-Gomez G, Gray SL, Yetukuri L, Shimomura K, Virtue S, Campbell M, Curtis RK, Jimenez-Linan M, Blount M, Yeo GS, Lopez M, Seppänen-Laakso T, Ashcroft FM, Oresic M, Vidal-Puig A. PPAR gamma 2 prevents lipotoxicity by controlling adipose tissue expandability and peripheral lipid metabolism. Plos Genetics. 3: e64. PMID 17465682 DOI: 10.1371/Journal.Pgen.0030064  0.306
2007 Olofsson CS, Collins S, Bengtsson M, Eliasson L, Salehi A, Shimomura K, Tarasov A, Holm C, Ashcroft F, Rorsman P. Long-term exposure to glucose and lipids inhibits glucose-induced insulin secretion downstream of granule fusion with plasma membrane. Diabetes. 56: 1888-97. PMID 17456851 DOI: 10.2337/Db06-1150  0.388
2007 Tammaro P, Ashcroft F. The Kir6.2-F333I mutation differentially modulates KATP channels composed of SUR1 or SUR2 subunits Journal of Physiology. 581: 1259-1269. PMID 17395632 DOI: 10.1113/Jphysiol.2007.130211  0.543
2007 Zhang Q, Bengtsson M, Partridge C, Salehi A, Braun M, Cox R, Eliasson L, Johnson PR, Renström E, Schneider T, Berggren PO, Göpel S, Ashcroft FM, Rorsman P. R-type Ca(2+)-channel-evoked CICR regulates glucose-induced somatostatin secretion. Nature Cell Biology. 9: 453-60. PMID 17369816 DOI: 10.1038/Ncb1563  0.534
2007 Haider S, Khalid S, Tucker SJ, Ashcroft FM, Sansom MS. Molecular dynamics simulations of inwardly rectifying (Kir) potassium channels: a comparative study. Biochemistry. 46: 3643-52. PMID 17326663 DOI: 10.1021/Bi062210F  0.619
2007 Ma X, Zubcevic L, Brüning JC, Ashcroft FM, Burdakov D. Electrical inhibition of identified anorexigenic POMC neurons by orexin/hypocretin. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 27: 1529-33. PMID 17301161 DOI: 10.1523/Jneurosci.3583-06.2007  0.763
2006 Tammaro P, Ashcroft FM. Keeping the heart going: a new role for KATP channels. The Journal of Physiology. 577: 767. PMID 17068097 DOI: 10.1113/Jphysiol.2006.123018  0.467
2006 Tarasov AI, Welters HJ, Senkel S, Ryffel GU, Hattersley AT, Morgan NG, Ashcroft FM. A Kir6.2 mutation causing neonatal diabetes impairs electrical activity and insulin secretion from INS-1 beta-cells. Diabetes. 55: 3075-82. PMID 17065345 DOI: 10.2337/Db06-0637  0.584
2006 Freeman H, Shimomura K, Cox RD, Ashcroft FM. Nicotinamide nucleotide transhydrogenase: a link between insulin secretion, glucose metabolism and oxidative stress. Biochemical Society Transactions. 34: 806-10. PMID 17052203 DOI: 10.1042/Bst0340806  0.456
2006 Heusser K, Yuan H, Neagoe I, Tarasov AI, Ashcroft FM, Schwappach B. Scavenging of 14-3-3 proteins reveals their involvement in the cell-surface transport of ATP-sensitive K+ channels. Journal of Cell Science. 119: 4353-63. PMID 17038548 DOI: 10.1242/Jcs.03196  0.481
2006 Girard CA, Shimomura K, Proks P, Absalom N, Castano L, Perez de Nanclares G, Ashcroft FM. Functional analysis of six Kir6.2 (KCNJ11) mutations causing neonatal diabetes. Pflã¼Gers Archiv : European Journal of Physiology. 453: 323-32. PMID 17021801 DOI: 10.1007/S00424-006-0112-3  0.59
2006 Tarasov AI, Girard CA, Ashcroft FM. ATP sensitivity of the ATP-sensitive K+ channel in intact and permeabilized pancreatic beta-cells. Diabetes. 55: 2446-54. PMID 16936192 DOI: 10.2337/Db06-0360  0.585
2006 Pearson ER, Flechtner I, Njølstad PR, Malecki MT, Flanagan SE, Larkin B, Ashcroft FM, Klimes I, Codner E, Iotova V, Slingerland AS, Shield J, Robert JJ, Holst JJ, Clark PM, et al. Switching from insulin to oral sulfonylureas in patients with diabetes due to Kir6.2 mutations. The New England Journal of Medicine. 355: 467-77. PMID 16885550 DOI: 10.1056/Nejmoa061759  0.515
2006 Freeman HC, Hugill A, Dear NT, Ashcroft FM, Cox RD. Deletion of nicotinamide nucleotide transhydrogenase: a new quantitive trait locus accounting for glucose intolerance in C57BL/6J mice. Diabetes. 55: 2153-6. PMID 16804088 DOI: 10.2337/Db06-0358  0.319
2006 Plum L, Ma X, Hampel B, Balthasar N, Coppari R, Münzberg H, Shanabrough M, Burdakov D, Rother E, Janoschek R, Alber J, Belgardt BF, Koch L, Seibler J, Schwenk F, ... ... Ashcroft FM, et al. Enhanced PIP3 signaling in POMC neurons causes KATP channel activation and leads to diet-sensitive obesity. The Journal of Clinical Investigation. 116: 1886-901. PMID 16794735 DOI: 10.1172/Jci27123  0.652
2006 Proks P, Girard C, Baevre H, Njølstad PR, Ashcroft FM. Functional effects of mutations at F35 in the NH2-terminus of Kir6.2 (KCNJ11), causing neonatal diabetes, and response to sulfonylurea therapy. Diabetes. 55: 1731-7. PMID 16731836 DOI: 10.2337/Db05-1420  0.57
2006 Shimomura K, Girard CA, Proks P, Nazim J, Lippiat JD, Cerutti F, Lorini R, Ellard S, Hattersley AT, Barbetti F, Ashcroft FM. Mutations at the same residue (R50) of Kir6.2 (KCNJ11) that cause neonatal diabetes produce different functional effects. Diabetes. 55: 1705-12. PMID 16731833 DOI: 10.2337/Db05-1640  0.556
2006 Proks P, Arnold AL, Bruining J, Girard C, Flanagan SE, Larkin B, Colclough K, Hattersley AT, Ashcroft FM, Ellard S. A heterozygous activating mutation in the sulphonylurea receptor SUR1 (ABCC8) causes neonatal diabetes. Human Molecular Genetics. 15: 1793-800. PMID 16613899 DOI: 10.1093/Hmg/Ddl101  0.513
2006 Ashcroft FM. From molecule to malady. Nature. 440: 440-7. PMID 16554803 DOI: 10.1038/Nature04707  0.427
2006 Ashcroft FM. K(ATP) channels and insulin secretion: a key role in health and disease. Biochemical Society Transactions. 34: 243-6. PMID 16545085 DOI: 10.1042/Bst20060243  0.595
2006 Deacon RM, Brook RC, Meyer D, Haeckel O, Ashcroft FM, Miki T, Seino S, Liss B. Behavioral phenotyping of mice lacking the K ATP channel subunit Kir6.2. Physiology & Behavior. 87: 723-33. PMID 16530794 DOI: 10.1016/J.Physbeh.2006.01.013  0.492
2006 Freeman H, Shimomura K, Horner E, Cox RD, Ashcroft FM. Nicotinamide nucleotide transhydrogenase: a key role in insulin secretion. Cell Metabolism. 3: 35-45. PMID 16399503 DOI: 10.1016/J.Cmet.2005.10.008  0.389
2006 Tammaro P, Proks P, Ashcroft FM. Functional effects of naturally occurring KCNJ11 mutations causing neonatal diabetes on cloned cardiac KATP channels. The Journal of Physiology. 571: 3-14. PMID 16339180 DOI: 10.1113/Jphysiol.2005.099168  0.586
2006 Hörster F, Hattersley A, Ashcroft F, Grulich-Henn J, Bast T, Fuchs U, Rating D, Wolf N, Ebinger F. Successful therapy with glibenclamid in a patient with a muation of KIR 6.2 subunit of the ATP-sensitive potassium channel Neuropediatrics. 37. DOI: 10.1055/S-2006-953620  0.487
2005 Mikhailov MV, Campbell JD, de Wet H, Shimomura K, Zadek B, Collins RF, Sansom MS, Ford RC, Ashcroft FM. 3-D structural and functional characterization of the purified KATP channel complex Kir6.2-SUR1. The Embo Journal. 24: 4166-75. PMID 16308567 DOI: 10.1038/Sj.Emboj.7600877  0.522
2005 Hattersley AT, Ashcroft FM. Activating mutations in Kir6.2 and neonatal diabetes: new clinical syndromes, new scientific insights, and new therapy. Diabetes. 54: 2503-13. PMID 16123337 DOI: 10.2337/Diabetes.54.9.2503  0.559
2005 Proks P, Girard C, Ashcroft FM. Functional effects of KCNJ11 mutations causing neonatal diabetes: enhanced activation by MgATP. Human Molecular Genetics. 14: 2717-26. PMID 16087682 DOI: 10.1093/Hmg/Ddi305  0.594
2005 Ashcroft FM. ATP-sensitive potassium channelopathies: focus on insulin secretion. The Journal of Clinical Investigation. 115: 2047-58. PMID 16075046 DOI: 10.1172/Jci25495  0.577
2005 Tammaro P, Girard C, Molnes J, Njølstad PR, Ashcroft FM. Kir6.2 mutations causing neonatal diabetes provide new insights into Kir6.2-SUR1 interactions. The Embo Journal. 24: 2318-30. PMID 15962003 DOI: 10.1038/Sj.Emboj.7600715  0.558
2005 Haider S, Antcliff JF, Proks P, Sansom MS, Ashcroft FM. Focus on Kir6.2: a key component of the ATP-sensitive potassium channel. Journal of Molecular and Cellular Cardiology. 38: 927-36. PMID 15910877 DOI: 10.1016/J.Yjmcc.2005.01.007  0.596
2005 Proks P, Girard C, Haider S, Gloyn AL, Hattersley AT, Sansom MS, Ashcroft FM. A gating mutation at the internal mouth of the Kir6.2 pore is associated with DEND syndrome. Embo Reports. 6: 470-5. PMID 15864298 DOI: 10.1038/Sj.Embor.7400393  0.562
2005 Haider S, Grottesi A, Hall BA, Ashcroft FM, Sansom MS. Conformational dynamics of the ligand-binding domain of inward rectifier K channels as revealed by molecular dynamics simulations: toward an understanding of Kir channel gating. Biophysical Journal. 88: 3310-20. PMID 15749783 DOI: 10.1529/Biophysj.104.052019  0.449
2005 Toye AA, Lippiat JD, Proks P, Shimomura K, Bentley L, Hugill A, Mijat V, Goldsworthy M, Moir L, Haynes A, Quarterman J, Freeman HC, Ashcroft FM, Cox RD. A genetic and physiological study of impaired glucose homeostasis control in C57BL/6J mice. Diabetologia. 48: 675-86. PMID 15729571 DOI: 10.1007/S00125-005-1680-Z  0.372
2005 Gloyn AL, Reimann F, Girard C, Edghill EL, Proks P, Pearson ER, Temple IK, Mackay DJ, Shield JP, Freedenberg D, Noyes K, Ellard S, Ashcroft FM, Gribble FM, Hattersley AT. Relapsing diabetes can result from moderately activating mutations in KCNJ11. Human Molecular Genetics. 14: 925-34. PMID 15718250 DOI: 10.1093/Hmg/Ddi086  0.581
2005 Hansen AM, Hansen JB, Carr RD, Ashcroft FM, Wahl P. Kir6.2-dependent high-affinity repaglinide binding to beta-cell K(ATP) channels. British Journal of Pharmacology. 144: 551-7. PMID 15678092 DOI: 10.1038/Sj.Bjp.0706082  0.524
2005 Antcliff JF, Haider S, Proks P, Sansom MS, Ashcroft FM. Functional analysis of a structural model of the ATP-binding site of the KATP channel Kir6.2 subunit. The Embo Journal. 24: 229-39. PMID 15650751 DOI: 10.1038/Sj.Emboj.7600487  0.519
2005 Tarasov A, Dusonchet J, Ashcroft F. Metabolic regulation of the pancreatic beta-cell ATP-sensitive K+ channel: a pas de deux. Diabetes. S113-22. PMID 15561898 DOI: 10.2337/Diabetes.53.Suppl_3.S113  0.562
2004 Burdakov D, Alexopoulos H, Vincent A, Ashcroft FM. Low-voltage-activated A-current controls the firing dynamics of mouse hypothalamic orexin neurons. The European Journal of Neuroscience. 20: 3281-5. PMID 15610160 DOI: 10.1111/J.1460-9568.2004.03815.X  0.609
2004 Proks P, Antcliff JF, Lippiat J, Gloyn AL, Hattersley AT, Ashcroft FM. Molecular basis of Kir6.2 mutations associated with neonatal diabetes or neonatal diabetes plus neurological features. Proceedings of the National Academy of Sciences of the United States of America. 101: 17539-44. PMID 15583126 DOI: 10.1073/Pnas.0404756101  0.582
2004 Campbell JD, Proks P, Lippiat JD, Sansom MS, Ashcroft FM. Identification of a functionally important negatively charged residue within the second catalytic site of the SUR1 nucleotide-binding domains. Diabetes. 53: S123-7. PMID 15561899 DOI: 10.2337/Diabetes.53.Suppl_3.S123  0.531
2004 Yang SB, Proks P, Ashcroft FM, Rupnik M. Inhibition of ATP-sensitive potassium channels by haloperidol. British Journal of Pharmacology. 143: 960-7. PMID 15533888 DOI: 10.1038/Sj.Bjp.0706017  0.578
2004 Campbell JD, Deol SS, Ashcroft FM, Kerr ID, Sansom MS. Nucleotide-dependent conformational changes in HisP: molecular dynamics simulations of an ABC transporter nucleotide-binding domain. Biophysical Journal. 87: 3703-15. PMID 15377525 DOI: 10.1529/Biophysj.104.046870  0.311
2004 Gloyn AL, Pearson ER, Antcliff JF, Proks P, Bruining GJ, Slingerland AS, Howard N, Srinivasan S, Silva JM, Molnes J, Edghill EL, Frayling TM, Temple IK, Mackay D, Shield JP, ... ... Ashcroft FM, et al. Activating mutations in the gene encoding the ATP-sensitive potassium-channel subunit Kir6.2 and permanent neonatal diabetes. The New England Journal of Medicine. 350: 1838-49. PMID 15115830 DOI: 10.1056/Nejmoa032922  0.479
2004 Ashcroft FM, Rorsman P. Molecular defects in insulin secretion in type-2 diabetes. Reviews in Endocrine & Metabolic Disorders. 5: 135-42. PMID 15041789 DOI: 10.1023/B:Remd.0000021435.87776.A7  0.309
2004 Park EJ, Bae JH, Kim SY, Lim JG, Baek WK, Kwon TK, Suh SI, Park JW, Lee IK, Ashcroft FM, Song DK. Inhibition of ATP-sensitive K+ channels by taurine through a benzamido-binding site on sulfonylurea receptor 1. Biochemical Pharmacology. 67: 1089-96. PMID 15006545 DOI: 10.1016/J.Bcp.2003.11.003  0.593
2004 Dabrowski M, Tarasov A, Ashcroft FM. Mapping the architecture of the ATP-binding site of the KATP channel subunit Kir6.2. The Journal of Physiology. 557: 347-54. PMID 15004210 DOI: 10.1113/Jphysiol.2003.059105  0.478
2004 Ashcroft F, Rorsman P. Type 2 diabetes mellitus: not quite exciting enough? Human Molecular Genetics. 13: R21-31. PMID 14734629 DOI: 10.1093/Hmg/Ddh066  0.313
2004 Tsuboi T, Lippiat JD, Ashcroft FM, Rutter GA. ATP-dependent interaction of the cytosolic domains of the inwardly rectifying K+ channel Kir6.2 revealed by fluorescence resonance energy transfer. Proceedings of the National Academy of Sciences of the United States of America. 101: 76-81. PMID 14681552 DOI: 10.1073/Pnas.0306347101  0.562
2003 Campbell JD, Sansom MSP, Ashcroft FM. Potassium channel regulation. Structural insights into the function of the nucleotide-binding domains of the human sulphonylurea receptor Embo Reports. 4: 1038-1042. PMID 14593442 DOI: 10.1038/Sj.Embor.7400003  0.44
2003 Dabrowski M, Larsen T, Ashcroft FM, Bondo Hansen J, Wahl P. Potent and selective activation of the pancreatic beta-cell type K(ATP) channel by two novel diazoxide analogues. Diabetologia. 46: 1375-82. PMID 12961066 DOI: 10.1007/S00125-003-1198-1  0.563
2003 Burdakov D, Liss B, Ashcroft FM. Orexin excites GABAergic neurons of the arcuate nucleus by activating the sodium--calcium exchanger. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 23: 4951-7. PMID 12832517 DOI: 10.1523/Jneurosci.23-12-04951.2003  0.601
2003 Trapp S, Haider S, Jones P, Sansom MSP, Ashcroft FM. Identification of residues contributing to the ATP binding site of Kir6.2 Embo Journal. 22: 2903-2912. PMID 12805206 DOI: 10.1093/Emboj/Cdg282  0.514
2003 Dabrowski M, Trapp S, Ashcroft FM. Pyridine nucleotide regulation of the KATP channel Kir6.2/SUR1 expressed in Xenopus oocytes. The Journal of Physiology. 550: 357-63. PMID 12766240 DOI: 10.1113/Jphysiol.2003.041715  0.554
2003 Kuo A, Gulbis JM, Antcliff JF, Rahman T, Lowe ED, Zimmer J, Cuthbertson J, Ashcroft FM, Ezaki T, Doyle DA. Crystal structure of the potassium channel KirBac1.1 in the closed state. Science (New York, N.Y.). 300: 1922-6. PMID 12738871 DOI: 10.1126/Science.1085028  0.466
2003 Capener CE, Proks P, Ashcroft FM, Sansom MSP. Filter flexibility in a mammalian K channel: Models and simulations of Kir6.2 mutants Biophysical Journal. 84: 2345-2356. PMID 12668443 DOI: 10.1016/S0006-3495(03)75040-1  0.414
2003 Reimann F, Huopio H, Dabrowski M, Proks P, Gribble FM, Laakso M, Otonkoski T, Ashcroft FM. Characterisation of new KATP-channel mutations associated with congenital hyperinsulinism in the Finnish population. Diabetologia. 46: 241-9. PMID 12627323 DOI: 10.1007/S00125-002-1014-3  0.697
2003 Reimann F, Dabrowski M, Jones P, Gribble FM, Ashcroft FM. Analysis of the differential modulation of sulphonylurea block of beta-cell and cardiac ATP-sensitive K+ (K(ATP)) channels by Mg-nucleotides. The Journal of Physiology. 547: 159-68. PMID 12562963 DOI: 10.1113/jphysiol.2002.031625  0.692
2003 Huopio H, Otonkoski T, Vauhkonen I, Reimann F, Ashcroft FM, Laakso M. A new subtype of autosomal dominant diabetes attributable to a mutation in the gene for sulfonylurea receptor 1. Lancet (London, England). 361: 301-7. PMID 12559865 DOI: 10.1016/S0140-6736(03)12325-2  0.407
2003 Proks P, Antcliff JF, Ashcroft FM. The ligand-sensitive gate of a potassium channel lies close to the selectivity filter Embo Reports. 4: 70-75. PMID 12524524 DOI: 10.1038/Sj.Embor.Embor708  0.495
2003 Reimann F, Dabrowski M, Jones P, Gribble FM, Ashcroft FM. Analysis of the differential modulation of sulphonylurea block of β‐cell and cardiac ATP‐sensitive K+ (KATP) channels by Mg‐nucleotides The Journal of Physiology. 547: 159-168. DOI: 10.1111/J.1469-7793.2003.00159.X  0.699
2002 Lippiat JD, Albinson SL, Ashcroft FM. Interaction of the cytosolic domains of the Kir6.2 subunit of the KATP channel is modulated by sulfonylureas Diabetes. 51: S377-S380. PMID 12475778 DOI: 10.2337/Diabetes.51.2007.S377  0.394
2002 Proks P, Reimann F, Green N, Gribble F, Ashcroft F. Sulfonylurea stimulation of insulin secretion. Diabetes. 51: S368-76. PMID 12475777 DOI: 10.2337/Diabetes.51.2007.S368  0.716
2002 Burdakov D, Ashcroft FM. Shedding new light on brain metabolism and glial function. The Journal of Physiology. 544: 334. PMID 12381806 DOI: 10.1113/Jphysiol.2002.029090  0.657
2002 Hansen AMK, Christensen IT, Hansen JB, Carr RD, Ashcroft FM, Wahl P. Differential interactions of nateglinide and repaglinide on the human β-cell sulphonylurea receptor 1 Diabetes. 51: 2789-2795. PMID 12196472 DOI: 10.2337/Diabetes.51.9.2789  0.489
2002 Gros L, Trapp S, Dabrowski M, Ashcroft FM, Bataille D, Blache P. Characterization of two novel forms of the rat sulphonylurea receptor SUR1A2 and SUR1BDelta31. British Journal of Pharmacology. 137: 98-106. PMID 12183335 DOI: 10.1038/Sj.Bjp.0704836  0.548
2002 Matsuo M, Dabrowski M, Ueda K, Ashcroft FM. Mutations in the linker domain of NBD2 of SUR inhibit transduction but not nucleotide binding. The Embo Journal. 21: 4250-8. PMID 12169627 DOI: 10.1093/Emboj/Cdf419  0.51
2002 Burdakov D, Ashcroft FM. Cholecystokinin tunes firing of an electrically distinct subset of arcuate nucleus neurons by activating A-Type potassium channels. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 22: 6380-7. PMID 12151516 DOI: 10.1523/Jneurosci.22-15-06380.2002  0.629
2002 Dabrowski M, Ashcroft FM, Ashfield R, Lebrun P, Pirotte B, Egebjerg J, Bondo Hansen J, Wahl P. The novel diazoxide analog 3-isopropylamino-7-methoxy-4H-1,2,4-benzothiadiazine 1,1-dioxide is a selective Kir6.2/SUR1 channel opener. Diabetes. 51: 1896-906. PMID 12031979 DOI: 10.2337/Diabetes.51.6.1896  0.56
2001 Jones PA, Tucker SJ, Ashcroft FM. Multiple sites of interaction between the intracellular domains of an inwardly rectifying potassium channel, Kir6.2. Febs Letters. 508: 85-9. PMID 11707273 DOI: 10.1016/S0014-5793(01)03023-X  0.617
2001 Proks P, Capener CE, Jones P, Ashcroft FM. Mutations within the P-loop of Kir6.2 modulate the intraburst kinetics of the ATP-sensitive potassium channel Journal of General Physiology. 118: 341-353. PMID 11585848 DOI: 10.1085/Jgp.118.4.341  0.552
2001 Reimann F, Ashcroft FM, Gribble FM. Structural basis for the interference between nicorandil and sulfonylurea action. Diabetes. 50: 2253-9. PMID 11574406 DOI: 10.2337/Diabetes.50.10.2253  0.711
2001 Lawrence CL, Proks P, Rodrigo GC, Jones P, Hayabuchi Y, Standen NB, Ashcroft FM. Gliclazide produces high-affinity block of KATP, channels in mouse isolated pancreatic beta cells but not rat heart or arterial smooth muscle cells Diabetologia. 44: 1019-1025. PMID 11484080 DOI: 10.1007/S001250100595  0.459
2001 Dabrowski M, Wahl P, Holmes WE, Ashcroft FM. Effect of repaglinide on cloned beta cell, cardiac and smooth muscle types of ATP-sensitive potassium channels. Diabetologia. 44: 747-56. PMID 11440368 DOI: 10.1007/S001250051684  0.547
2001 Loussouarn G, Pike LJ, Ashcroft FM, Makhina EN, Nichols CG. Dynamic sensitivity of ATP-sensitive K(+) channels to ATP. The Journal of Biological Chemistry. 276: 29098-103. PMID 11395495 DOI: 10.1074/Jbc.M102365200  0.559
2001 Song DK, Ashcroft FM. Glimepiride block of cloned β-cell, cardiac and smooth muscle K ATP channels British Journal of Pharmacology. 133: 193-199. PMID 11325810 DOI: 10.1038/Sj.Bjp.0704062  0.539
2001 Miki T, Liss B, Minami K, Shiuchi T, Saraya A, Kashima Y, Horiuchi M, Ashcroft F, Minokoshi Y, Roeper J, Seino S. ATP-sensitive K+ channels in the hypothalamus are essential for the maintenance of glucose homeostasis. Nature Neuroscience. 4: 507-12. PMID 11319559 DOI: 10.1038/87455  0.731
2001 Reimann F, Proks P, Ashcroft FM. Effects of mitiglinide (S 21403) on Kir6.2/SUR1, Kir6.2/SUR2A and Kir6.2/SUR2B types of ATP-sensitive potassium channel. British Journal of Pharmacology. 132: 1542-8. PMID 11264248 DOI: 10.1038/Sj.Bjp.0703962  0.559
2001 Proks P, Jones P, Ashcroft FM. Interaction of stilbene disulphonates with cloned K ATP channels British Journal of Pharmacology. 132: 973-982. PMID 11226127 DOI: 10.1038/Sj.Bjp.0703916  0.56
2001 Song DK, Ashcroft FM. ATP Modulation of ATP-sensitive Potassium Channel ATP Sensitivity Varies with the Type of SUR Subunit Journal of Biological Chemistry. 276: 7143-7149. PMID 11115512 DOI: 10.1074/Jbc.M009959200  0.563
2001 Gribble FM, Ashcroft FM. Differentsirovannaya chuvstvitel'nost' ?-kletochnykh i ekstrapankreaticheskikh ATF zavisimykh K kanalov k gliklazidu Diabetes Mellitus. 4: 13-15. DOI: 10.14341/2072-0351-6101  0.484
2000 Ashcroft FM, Gribble FM. New windows on the mechanism of action of K(ATP) channel openers. Trends in Pharmacological Sciences. 21: 439-45. PMID 11121575 DOI: 10.1016/S0165-6147(00)01563-7  0.69
2000 Reimann F, Gribble FM, Ashcroft FM. Differential response of K(ATP) channels containing SUR2A or SUR2B subunits to nucleotides and pinacidil. Molecular Pharmacology. 58: 1318-25. PMID 11093769 DOI: 10.1124/Mol.58.6.1318  0.702
2000 Trapp S, Ashcroft FM. Direct interaction of Na-azide with the K(ATP) channel British Journal of Pharmacology. 131: 1105-1112. PMID 11082117 DOI: 10.1038/Sj.Bjp.0703680  0.494
2000 Gribble FM, Ashcroft FM. Sulfonylurea sensitivity of adenosine triphosphate-sensitive potassium channels from beta cells and extrapancreatic tissues. Metabolism: Clinical and Experimental. 49: 3-6. PMID 11078468  0.691
2000 Ashcroft FM. The Yin and Yang of the K(ATP) channel Journal of Physiology. 528: 405. PMID 11060118 DOI: 10.1111/J.1469-7793.2000.T01-1-00405.X  0.536
2000 Gribble FM, Davis TM, Higham CE, Clark A, Ashcroft FM. The antimalarial agent mefloquine inhibits ATP-sensitive K-channels. British Journal of Pharmacology. 131: 756-60. PMID 11030725 DOI: 10.1038/Sj.Bjp.0703638  0.711
2000 Huopio H, Reimann F, Ashfield R, Komulainen J, Lenko HL, Rahier J, Vauhkonen I, Kere J, Laakso M, Ashcroft F, Otonkoski T. Dominantly inherited hyperinsulinism caused by a mutation in the sulfonylurea receptor type 1. The Journal of Clinical Investigation. 106: 897-906. PMID 11018078 DOI: 10.1172/Jci9804  0.507
2000 Ashcroft FM, Gribble FM. Tissue-specific effects of sulfonylureas: lessons from studies of cloned K(ATP) channels. Journal of Diabetes and Its Complications. 14: 192-6. PMID 11004427 DOI: 10.1016/S1056-8727(00)00081-7  0.713
2000 Matsuo M, Trapp S, Tanizawa Y, Kioka N, Amachi T, Oka Y, Ashcroft FM, Ueda K. Functional analysis of a mutant sulfonylurea receptor, SUR1-R1420C, that is responsible for persistent hyperinsulinemic hypoglycemia of infancy Journal of Biological Chemistry. 275: 41184-41191. PMID 10993895 DOI: 10.1074/Jbc.M006503200  0.583
2000 Gribble FM, Loussouarn G, Tucker SJ, Zhao C, Nichols CG, Ashcroft FM. A novel method for measurement of submembrane ATP concentration. The Journal of Biological Chemistry. 275: 30046-9. PMID 10866996 DOI: 10.1074/Jbc.M001010200  0.716
2000 Tanabe K, Tucker SJ, Ashcroft FM, Proks P, Kioka N, Amachi T, Ueda K. Direct photoaffinity labeling of Kir6.2 by [gamma-(32)P]ATP-[gamma]4-azidoanilide. Biochemical and Biophysical Research Communications. 272: 316-9. PMID 10833411 DOI: 10.1006/Bbrc.2000.2780  0.646
2000 Gribble FM, Reimann F, Ashfield R, Ashcroft FM. Nucleotide modulation of pinacidil stimulation of the cloned K(ATP) channel Kir6.2/SUR2A. Molecular Pharmacology. 57: 1256-61. PMID 10825398  0.658
2000 Gribble FM, Ashcroft FM. Sulfonylurea sensitivity of adenosine triphosphate-sensitive potassium channels fromcells and extrapancreatic tissues Metabolism-Clinical and Experimental. 49: 3-6. DOI: 10.1053/Meta.2000.17822  0.718
1999 Smith PA, Proks P, Ashcroft FM. Quantal analysis of 5-hydroxytryptamine release from mouse pancreatic beta-cells. The Journal of Physiology. 521: 651-64. PMID 10601496 DOI: 10.1111/J.1469-7793.1999.00651.X  0.426
1999 Sakura H, Trapp S, Liss B, Ashcroft FM. Altered functional properties of K(ATP) channel conferred by a novel splice variant of SUR1 Journal of Physiology. 521: 337-350. PMID 10581306 DOI: 10.1111/J.1469-7793.1999.00337.X  0.583
1999 Matsuo M, Tucker SJ, Ashcroft FM, Amachi T, Ueda K. NEM modification prevents high-affinity ATP binding to the first nucleotide binding fold of the sulphonylurea receptor, SUR1. Febs Letters. 458: 292-4. PMID 10570926 DOI: 10.1016/S0014-5793(99)01170-9  0.631
1999 Tucker SJ, Ashcroft FM. Mapping of the physical interaction between the intracellular domains of an inwardly rectifying potassium channel, Kir6.2. The Journal of Biological Chemistry. 274: 33393-7. PMID 10559219 DOI: 10.1074/Jbc.274.47.33393  0.642
1999 Le Brigand L, Virsolvy A, Manechez D, Godfroid JJ, Guardiola-Lemaître B, Gribble FM, Ashcroft FM, Bataille D. In vitro mechanism of action on insulin release of S-22068, a new putative antidiabetic compound. British Journal of Pharmacology. 128: 1021-6. PMID 10556939 DOI: 10.1038/Sj.Bjp.0702883  0.658
1999 Reimann F, Ryder TJ, Tucker SJ, Ashcroft FM. The role of lysine 185 in the kir6.2 subunit of the ATP-sensitive channel in channel inhibition by ATP. The Journal of Physiology. 520: 661-9. PMID 10545134 DOI: 10.1111/J.1469-7793.1999.00661.X  0.708
1999 Ashcroft FM, Gribble FM. ATP-sensitive K+ channels and insulin secretion: their role in health and disease. Diabetologia. 42: 903-19. PMID 10491749 DOI: 10.1007/S001250051247  0.654
1999 Proks P, Ashfield R, Ashcroft FM. Interaction of vanadate with the cloned beta cell K(ATP) channel Journal of Biological Chemistry. 274: 25393-25397. PMID 10464267 DOI: 10.1074/Jbc.274.36.25393  0.587
1999 Reimann F, Ashcroft FM. Inwardly rectifying potassium channels Current Opinion in Cell Biology. 11: 503-508. PMID 10449331 DOI: 10.1016/S0955-0674(99)80073-8  0.537
1999 Gribble FM, Ashcroft FM. Differential sensitivity of beta-cell and extrapancreatic K(ATP) channels to gliclazide. Diabetologia. 42: 845-8. PMID 10440127 DOI: 10.1007/S001250051236  0.687
1999 Reimann F, Tucker SJ, Proks P, Ashcroft FM. Involvement of the n-terminus of Kir6.2 in coupling to the sulphonylurea receptor. The Journal of Physiology. 518: 325-36. PMID 10381582 DOI: 10.1111/J.1469-7793.1999.0325P.X  0.693
1999 Ashfield R, Gribble FM, Ashcroft SJ, Ashcroft FM. Identification of the high-affinity tolbutamide site on the SUR1 subunit of the K(ATP) channel. Diabetes. 48: 1341-7. PMID 10342826 DOI: 10.2337/Diabetes.48.6.1341  0.701
1999 Otonkoski T, Ammälä C, Huopio H, Cote GJ, Chapman J, Cosgrove K, Ashfield R, Huang E, Komulainen J, Ashcroft FM, Dunne MJ, Kere J, Thomas PM. A point mutation inactivating the sulfonylurea receptor causes the severe form of persistent hyperinsulinemic hypoglycemia of infancy in Finland. Diabetes. 48: 408-15. PMID 10334322 DOI: 10.2337/Diabetes.48.2.408  0.468
1999 Dalle S, Smith P, Blache P, Le-Nguyen D, Le Brigand L, Bergeron F, Ashcroft FM, Bataille D. Miniglucagon (glucagon 19-29), a potent and efficient inhibitor of secretagogue-induced insulin release through a Ca2+ pathway. The Journal of Biological Chemistry. 274: 10869-76. PMID 10196164 DOI: 10.1074/Jbc.274.16.10869  0.532
1999 Tanabe K, Tucker SJ, Matsuo M, Proks P, Ashcroft FM, Seino S, Amachi T, Ueda K. Direct photoaffinity labeling of the Kir6.2 subunit of the ATP-sensitive K+ channel by 8-azido-ATP. The Journal of Biological Chemistry. 274: 3931-3. PMID 9933580 DOI: 10.1074/Jbc.274.7.3931  0.684
1999 Proks P, Gribble FM, Adhikari R, Tucker SJ, Ashcroft FM. Involvement of the N-terminus of Kir6.2 in the inhibition of the KATP channel by ATP. The Journal of Physiology. 514: 19-25. PMID 9831713 DOI: 10.1111/J.1469-7793.1999.019Af.X  0.757
1998 Ashcroft FM. Exciting times for PIP2 Science. 282: 1059-1060. PMID 9841452 DOI: 10.1126/Science.282.5391.1059  0.476
1998 Gribble FM, Proks P, Corkey BE, Ashcroft FM. Mechanism of cloned ATP-sensitive potassium channel activation by oleoyl-CoA. The Journal of Biological Chemistry. 273: 26383-7. PMID 9756869 DOI: 10.1074/Jbc.273.41.26383  0.716
1998 Gribble FM, Tucker SJ, Seino S, Ashcroft FM. Tissue specificity of sulfonylureas: studies on cloned cardiac and beta-cell K(ATP) channels. Diabetes. 47: 1412-8. PMID 9726229 DOI: 10.2337/Diabetes.47.9.1412  0.761
1998 Trapp S, Proks P, Tucker SJ, Ashcroft FM. Molecular analysis of ATP-sensitive K channel gating and implications for channel inhibition by ATP. The Journal of General Physiology. 112: 333-49. PMID 9725893 DOI: 10.1085/Jgp.112.3.333  0.704
1998 Trapp S, Tucker SJ, Ashcroft FM. Mechanism of ATP-sensitive K channel inhibition by sulfhydryl modification. The Journal of General Physiology. 112: 325-32. PMID 9725892 DOI: 10.1085/Jgp.112.3.325  0.712
1998 Tucker SJ, Ashcroft FM. A touching case of channel regulation: the ATP-sensitive K+ channel. Current Opinion in Neurobiology. 8: 316-20. PMID 9687347 DOI: 10.1016/S0959-4388(98)80055-X  0.702
1998 Ashcroft FM, Gribble FM. Correlating structure and function in ATP-sensitive K+ channels. Trends in Neurosciences. 21: 288-94. PMID 9683320 DOI: 10.1016/S0166-2236(98)01225-9  0.694
1998 Mikhailov MV, Proks P, Ashcroft FM, Ashcroft SJH. Expression of functionally active ATP-sensitive K-channels in insect cells using baculovirus Febs Letters. 429: 390-394. PMID 9662455 DOI: 10.1016/S0014-5793(98)00640-1  0.554
1998 Sakura H, Ashcroft SJH, Terauchi Y, Kadowaki T, Ashcroft FM. Glucose modulation of ATP-sensitive K-currents in wild-type, homozygous and heterozygous glucokinase knock-out mice Diabetologia. 41: 654-659. PMID 9662046 DOI: 10.1007/S001250050964  0.482
1998 Heron L, Virsolvy A, Peyrollier K, Gribble FM, Le Cam A, Ashcroft FM, Bataille D. Human alpha-endosulfine, a possible regulator of sulfonylurea-sensitive KATP channel: molecular cloning, expression and biological properties. Proceedings of the National Academy of Sciences of the United States of America. 95: 8387-91. PMID 9653196 DOI: 10.1073/Pnas.95.14.8387  0.669
1998 Tucker SJ, Gribble FM, Proks P, Trapp S, Ryder TJ, Haug T, Reimann F, Ashcroft FM. Molecular determinants of KATP channel inhibition by ATP. The Embo Journal. 17: 3290-6. PMID 9628866 DOI: 10.1093/Emboj/17.12.3290  0.774
1998 Gribble FM, Tucker SJ, Haug T, Ashcroft FM. MgATP activates the beta cell KATP channel by interaction with its SUR1 subunit. Proceedings of the National Academy of Sciences of the United States of America. 95: 7185-90. PMID 9618560 DOI: 10.1073/Pnas.95.12.7185  0.789
1998 Hughes SJ, Faehling M, Thorneley CW, Proks P, Ashcroft FM, Smith PA. Electrophysiological and metabolic characterization of single beta-cells and islets from diabetic GK rats. Diabetes. 47: 73-81. PMID 9421377 DOI: 10.2337/Diab.47.1.73  0.548
1997 Smith P, Millard PJ, Fewtrell CM, Ashcroft FM. Heterogeneity of beta-cell Ca2+ responses to glucose. Advances in Experimental Medicine and Biology. 426: 253-7. PMID 9544282 DOI: 10.1007/978-1-4899-1819-2_35  0.467
1997 Niki I, Coles B, Ashcroft FM, Ashcroft SJH. Effects of protein phosphorylation on the sulphonylurea receptor of the pancreatic β-cell Advances in Experimental Medicine and Biology. 426: 59-69. PMID 9544256 DOI: 10.1007/978-1-4899-1819-2_8  0.359
1997 Gribble FM, Tucker SJ, Ashcroft FM. The interaction of nucleotides with the tolbutamide block of cloned ATP-sensitive K+ channel currents expressed in Xenopus oocytes: a reinterpretation. The Journal of Physiology. 504: 35-45. PMID 9350615 DOI: 10.1111/J.1469-7793.1997.00035.X  0.75
1997 Proks P, Ashcroft FM. Phentolamine block of K(ATP) channels is mediated by Kir6.2 Proceedings of the National Academy of Sciences of the United States of America. 94: 11716-11720. PMID 9326676 DOI: 10.1073/Pnas.94.21.11716  0.603
1997 Trapp S, Tucker SJ, Ashcroft FM. Activation and inhibition of K-ATP currents by guanine nucleotides is mediated by different channel subunits. Proceedings of the National Academy of Sciences of the United States of America. 94: 8872-7. PMID 9238070 DOI: 10.1073/Pnas.94.16.8872  0.733
1997 Sakura H, Ashcroft FM. Identification of four trp1 gene variants murine pancreatic beta-cells. Diabetologia. 40: 528-32. PMID 9165220 DOI: 10.1007/S001250050711  0.364
1997 Tucker SJ, Gribble FM, Zhao C, Trapp S, Ashcroft FM. Truncation of Kir6.2 produces ATP-sensitive K+ channels in the absence of the sulphonylurea receptor. Nature. 387: 179-83. PMID 9144288 DOI: 10.1038/387179A0  0.789
1997 Gribble FM, Tucker SJ, Ashcroft FM. The essential role of the Walker A motifs of SUR1 in K-ATP channel activation by Mg-ADP and diazoxide. The Embo Journal. 16: 1145-52. PMID 9135131 DOI: 10.1093/Emboj/16.6.1145  0.79
1997 Smith PA, Sakura H, Coles B, Gummerson N, Proks P, Ashcroft FM. Electrogenic arginine transport mediates stimulus-secretion coupling in mouse pancreatic beta-cells. The Journal of Physiology. 499: 625-35. PMID 9130159 DOI: 10.1113/Jphysiol.1997.Sp021955  0.432
1997 Gribble FM, Ashfield R, Ammälä C, Ashcroft FM. Properties of cloned ATP-sensitive K+ currents expressed in Xenopus oocytes. The Journal of Physiology. 498: 87-98. PMID 9023770 DOI: 10.1113/Jphysiol.1997.Sp021843  0.702
1997 Karschin C, Ecke C, Ashcroft FM, Karschin A. Overlapping distribution of K(ATP) channel-forming Kir6.2 subunit and the sulfonylurea receptor SUR1 in rodent brain. Febs Letters. 401: 59-64. PMID 9003806 DOI: 10.1016/S0014-5793(96)01438-X  0.423
1997 Ashcroft FM. Mechanisms of the glycaemic effects of sulfonylureas. Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme. 28: 456-63. PMID 8911983 DOI: 10.1055/S-2007-979837  0.539
1997 Ammälä C, Moorhouse A, Ashcroft FM. The sulphonylurea receptor confers diazoxide sensitivity on the inwardly rectifying K+ channel Kir6.1 expressed in human embryonic kidney cells. The Journal of Physiology. 709-14. PMID 8865068 DOI: 10.1113/Jphysiol.1996.Sp021526  0.538
1997 Trapp S, Ashcroft FM. A metabolic sensor in action: News from the ATP-sensitive K+-channel News in Physiological Sciences. 12: 255-262. DOI: 10.1152/Physiologyonline.1997.12.6.255  0.531
1997 Faehling M, Ashcroft FM. Heterogeneity of β-cell secretion possible involvement of K-ATP channels Advances in Experimental Medicine and Biology. 426: 247-252.  0.411
1997 Smith P, Millard PJ, Fewtrell CMS, Ashcroft FM. Heterogeneity of β-cell Ca2+ responses to glucose Advances in Experimental Medicine and Biology. 426: 253-257.  0.305
1996 Proks P, Eliasson L, Ämmälä C, Rorsman P, Ashcroft FM. Ca2+- and GTP-dependent exocytosis in mouse pancreatic β-cells involves both common and distinct steps Journal of Physiology. 496: 255-264. PMID 8910213 DOI: 10.1113/Jphysiol.1996.Sp021682  0.32
1996 Sakura H, Wat N, Horton V, Millns H, Turner RC, Ashcroft FM. Sequence variations in the human Kir6.2 gene, a subunit of the beta-cell ATP-sensitive K-channel: no association with NIDDM in while Caucasian subjects or evidence of abnormal function when expressed in vitro. Diabetologia. 39: 1233-6. PMID 8897013 DOI: 10.1007/Bf02658512  0.493
1996 Eliasson L, Proks P, Ammälä C, Ashcroft FM, Bokvist K, Renström E, Rorsman P, Smith PA. Endocytosis of secretory granules in mouse pancreatic beta-cells evoked by transient elevation of cytosolic calcium. The Journal of Physiology. 493: 755-67. PMID 8799897 DOI: 10.1113/Jphysiol.1996.Sp021420  0.439
1996 Tucker SJ, Pessia M, Moorhouse AJ, Gribble F, Ashcroft FM, Maylie J, Adelman JP. Heteromeric channel formation and Ca2+-free media reduce the toxic effect of the weaver K(ir), 3.2 allele Febs Letters. 390: 253-257. PMID 8706871 DOI: 10.1016/0014-5793(96)00635-7  0.793
1996 Takano M, Ashcroft FM. The Ba2+ block of the ATP-sensitive K+ current of mouse pancreatic beta-cells. Pflugers Archiv : European Journal of Physiology. 431: 625-31. PMID 8596708 DOI: 10.1007/Bf02191912  0.463
1996 Ammälä C, Moorhouse A, Gribble F, Ashfield R, Proks P, Smith PA, Sakura H, Coles B, Ashcroft SJ, Ashcroft FM. Promiscuous coupling between the sulphonylurea receptor and inwardly rectifying potassium channels. Nature. 379: 545-8. PMID 8596634 DOI: 10.1038/379545A0  0.756
1995 Proks P, Ashcroft FM. Effects of divalent cations on exocytosis and endocytosis from single mouse pancreatic beta-cells. The Journal of Physiology. 487: 465-477. PMID 8558477 DOI: 10.1113/Jphysiol.1995.Sp020893  0.326
1995 Sakura H, Ammälä C, Smith PA, Gribble FM, Ashcroft FM. Cloning and functional expression of the cDNA encoding a novel ATP-sensitive potassium channel subunit expressed in pancreatic beta-cells, brain, heart and skeletal muscle. Febs Letters. 377: 338-44. PMID 8549751 DOI: 10.1016/0014-5793(95)01369-5  0.723
1995 Sakura H, Bond C, Warren-Perry M, Horsley S, Kearney L, Tucker S, Adelman J, Turner R, Ashcroft FM. Characterization and variation of a human inwardly-rectifying-K-channel gene (KCNJ6): a putative ATP-sensitive K-channel subunit. Febs Letters. 367: 193-7. PMID 7796919 DOI: 10.1016/0014-5793(95)00498-X  0.774
1995 Zhang Y, Warren-Perry M, Sakura H, Adelman J, Stoffel M, Bell GI, Ashcroft FM, Turner RC. No evidence for mutations in a putative beta-cell ATP-sensitive K+ channel subunit in MODY, NIDDM, or GDM. Diabetes. 44: 597-600. PMID 7729622 DOI: 10.2337/Diab.44.5.597  0.672
1995 Röper J, Ashcroft FM. Metabolic inhibition and low internal ATP activate K-ATP channels in rat dopaminergic substantia nigra neurones. Pflugers Archiv : European Journal of Physiology. 430: 44-54. PMID 7667078 DOI: 10.1007/Bf00373838  0.489
1995 Bond CT, Ämmälä C, Ashfield R, Blair TA, Gribble F, Khan RN, Lee K, Proks P, Rowe ICM, Sakura H, Ashford MJ, Adelman JP, Ashcroft FM. Cloning and functional expression of the cDNA encoding an inwardly-rectifying potassium channel expressed in pancreatic β-cells and in the brain Febs Letters. 367: 61-66. PMID 7601286 DOI: 10.1016/0014-5793(95)00497-W  0.772
1995 Yasuda K, Sakura H, Mori Y, Iwamoto K, Shimokawa K, Kadowaki H, Hagura R, Akanuma Y, Adelman JP, Yazaki Y, Ashcroft FM, Kadowaki T. No Evidence for Mutations in a Putative Subunit of the β-Cell ATP-Sensitive Potassium Channel (K-ATP Channel) in Japanese NIDDM Patients Biochemical and Biophysical Research Communications. 211: 1036-1040. PMID 7598690 DOI: 10.1006/Bbrc.1995.1915  0.725
1995 Smith PA, Duchen MR, Ashcroft FM. A fluorimetric and amperometric study of calcium and secretion in isolated mouse pancreatic beta-cells. Pflã¼Gers Archiv : European Journal of Physiology. 430: 808-18. PMID 7478937 DOI: 10.1007/Bf00386180  0.468
1994 Proks P, Takano M, Ashcroft FM. Effects of intracellular pH on ATP‐sensitive K+ channels in mouse pancreatic beta‐cells. The Journal of Physiology. 475: 33-44. PMID 8189391 DOI: 10.1113/Jphysiol.1994.Sp020047  0.554
1994 Smith PA, Williams BA, Ashcroft FM. Block of ATP-sensitive K+ channels in isolated mouse pancreatic beta-cells by 2,3-butanedione monoxime. British Journal of Pharmacology. 112: 143-9. PMID 8032636 DOI: 10.1111/J.1476-5381.1994.Tb13044.X  0.634
1994 Takano M, Ashcroft FM. Effects of internal chloride on ATP-sensitive K-channels in mouse pancreatic beta-cells. Pflugers Archiv : European Journal of Physiology. 428: 194-6. PMID 7971177 DOI: 10.1007/Bf00374859  0.551
1994 Kenna S, Röper J, Ho K, Hebert S, Ashcroft SJ, Ashcroft FM. Differential expression of the inwardly-rectifying K-channel ROMK1 in rat brain. Brain Research. Molecular Brain Research. 24: 353-6. PMID 7968375 DOI: 10.1016/0169-328X(94)90150-3  0.382
1994 Ashcroft FM, Proks P, Smith PA, Ammälä C, Bokvist K, Rorsman P. Stimulus-secretion coupling in pancreatic beta cells. Journal of Cellular Biochemistry. 55: 54-65. PMID 7929618 DOI: 10.1002/Jcb.240550007  0.514
1994 Ashcroft FM, Coles B, Kenna S, Proks P, Röper J, Reid J, Smith PA, Takano M. The KATP and Kv channels are distinct entities: a reply to Edwards and Weston. Cardiovascular Research. 28: 738-40; discussion 7. PMID 7923273 DOI: 10.1093/Cvr/28.6.738  0.577
1994 Ashcroft FM, Röper J. Transporters, channels and human disease. Current Opinion in Cell Biology. 5: 677-83. PMID 7504931 DOI: 10.1016/0955-0674(93)90139-H  0.432
1993 Duchen MR, Smith PA, Ashcroft FM. Substrate-dependent changes in mitochondrial function, intracellular free calcium concentration and membrane channels in pancreatic beta-cells. The Biochemical Journal. 294: 35-42. PMID 8363584 DOI: 10.1042/Bj2940035  0.497
1993 Proks P, Ashcroft FM. Modification of K-ATP channels in pancreatic beta-cells by trypsin. Pflugers Archiv : European Journal of Physiology. 424: 63-72. PMID 8351206 DOI: 10.1007/Bf00375103  0.57
1993 Williams BA, Smith PA, Leow K, Shimizu S, Gray DW, Ashcroft FM. Two types of potassium channel regulated by ATP in pancreatic B cells isolated from a type-2 diabetic human. Pflã¼Gers Archiv : European Journal of Physiology. 423: 265-73. PMID 8321630 DOI: 10.1007/Bf00374405  0.656
1993 Ämmälä C, Ashcroft FM, Rorsman P. Calcium-independent potentiation of insulin release by cyclic AMP in single β-cells Nature. 363: 356-358. PMID 7684514 DOI: 10.1038/363356A0  0.364
1992 Ashcroft FM. Ca2+ channels and excitation-contraction coupling. Current Opinion in Cell Biology. 3: 671-5. PMID 1663374 DOI: 10.1016/0955-0674(91)90040-6  0.403
1992 Oosawa Y, Ashcroft SJ, Ashcroft FM. Ca(2+)-activated K+ channels from an insulin-secreting cell line incorporated into planar lipid bilayers. Diabetologia. 35: 619-23. PMID 1379561 DOI: 10.1007/Bf00400252  0.524
1991 Kelly RP, Sutton R, Ashcroft FM. Voltage-activated calcium and potassium currents in human pancreatic beta-cells. The Journal of Physiology. 443: 175-92. PMID 1822525 DOI: 10.1113/Jphysiol.1991.Sp018829  0.378
1991 Ashcroft FM, Kerr AJ, Gibson JS, Williams BA. Amantadine and sparteine inhibit ATP‐regulated K‐currents in the insulin‐secreting β‐cell line, HIT‐T15 British Journal of Pharmacology. 104: 579-584. PMID 1797321 DOI: 10.1111/J.1476-5381.1991.Tb12472.X  0.493
1991 Bokvist K, Ammälä C, Ashcroft FM, Berggren PO, Larsson O, Rorsman P. Separate processes mediate nucleotide-induced inhibition and stimulation of the ATP-regulated K(+)-channels in mouse pancreatic beta-cells. Proceedings. Biological Sciences. 243: 139-44. PMID 1676517 DOI: 10.1098/Rspb.1991.0022  0.567
1990 Ashcroft FM, Kakei M. ATP-sensitive K+ channels in rat pancreatic beta-cells: modulation by ATP and Mg2+ ions. The Journal of Physiology. 416: 349-67. PMID 2691645 DOI: 10.1113/Jphysiol.1989.Sp017765  0.544
1990 Niki I, Ashcroft FM, Ashcroft SJ. The dependence on intracellular ATP concentration of ATP-sensitive K-channels and of Na,K-ATPase in intact HIT-T15 beta-cells. Febs Letters. 257: 361-4. PMID 2555221 DOI: 10.1016/0014-5793(89)81572-8  0.511
1990 Smith PA, Ashcroft FM, Rorsman P. Simultaneous recordings of glucose dependent electrical activity and ATP-regulated K(+)-currents in isolated mouse pancreatic beta-cells. Febs Letters. 261: 187-90. PMID 2407553 DOI: 10.1016/0014-5793(90)80667-8  0.564
1990 Ashcroft FM, Rorsman P. ATP-sensitive K+ channels: a link between B-cell metabolism and insulin secretion. Biochemical Society Transactions. 18: 109-11. PMID 2185070 DOI: 10.1042/Bst0180109  0.513
1990 Roeper J, Hainsworth AH, Ashcroft FM. Tolbutamide reverses membrane hyperpolarisation induced by activation of D2 receptors and GABAB receptors in isolated substantia nigra neurones. Pflã¼Gers Archiv : European Journal of Physiology. 416: 473-5. PMID 2169045 DOI: 10.1007/Bf00370758  0.729
1990 Ashcroft SJ, Ashcroft FM. Properties and functions of ATP-sensitive K-channels. Cellular Signalling. 2: 197-214. PMID 2119205 DOI: 10.1016/0898-6568(90)90048-F  0.52
1990 Betsholtz C, Baumann A, Kenna S, Ashcroft FM, Ashcroft SJ, Berggren PO, Grupe A, Pongs O, Rorsman P, Sandblom J. Expression of voltage-gated K+ channels in insulin-producing cells. Analysis by polymerase chain reaction. Febs Letters. 263: 121-6. PMID 1691985 DOI: 10.1016/0014-5793(90)80719-Y  0.467
1990 Ashcroft FM, Kelly RP, Smith PA. Two types of Ca channel in rat pancreatic beta-cells. Pflã¼Gers Archiv : European Journal of Physiology. 415: 504-6. PMID 1690385 DOI: 10.1007/Bf00373633  0.571
1989 Ashcroft FM, Kakei M, Kelly RP. Rubidium and sodium permeability of the ATP-sensitive K+ channel in single rat pancreatic beta-cells. The Journal of Physiology. 408: 413-29. PMID 2674421 DOI: 10.1113/Jphysiol.1989.Sp017467  0.477
1989 Ashcroft FM, Kakei M, Gibson JS, Gray DW, Sutton R. The ATP- and tolbutamide-sensitivity of the ATP-sensitive K-channel from human pancreatic B cells Diabetologia. 32: 591-598. PMID 2673893 DOI: 10.1007/Bf00285333  0.56
1989 Ashcroft FM, Rorsman P, Trube G. Single calcium channel activity in mouse pancreatic beta-cells. Annals of the New York Academy of Sciences. 560: 410-2. PMID 2545147 DOI: 10.1111/J.1749-6632.1989.Tb24123.X  0.43
1989 Findlay I, Ashcroft FM, Kelly RP, Rorsman P, Petersen OH, Trube G. Calcium currents in insulin-secreting beta-cells. Annals of the New York Academy of Sciences. 560: 403-9. PMID 2545146 DOI: 10.1111/J.1749-6632.1989.Tb24122.X  0.338
1989 Niki I, Kelly RP, Ashcroft SJ, Ashcroft FM. ATP-sensitive K-channels in HIT T15 beta-cells studied by patch-clamp methods, 86Rb efflux and glibenclamide binding. PflüGers Archiv : European Journal of Physiology. 415: 47-55. PMID 2516306 DOI: 10.1007/Bf00373140  0.513
1989 Smith PA, Rorsman P, Ashcroft FM. Modulation of dihydropyridine-sensitive Ca2+ channels by glucose metabolism in mouse pancreatic beta-cells. Nature. 342: 550-3. PMID 2479839 DOI: 10.1038/342550A0  0.574
1989 Rorsman P, Ashcroft FM, Trube G. Single Ca channel currents in mouse pancreatic B-cells. Pflugers Archiv : European Journal of Physiology. 412: 597-603. PMID 2463514 DOI: 10.1007/Bf00583760  0.494
1988 Ashcroft FM, Ashcroft SJ, Berggren PO, Betzholz C, Rorsman P, Trube G, Welsh M. Expression of K channels in Xenopus laevis oocytes injected with poly(A+) mRNA from the insulin-secreting beta-cell line, HIT T15. Febs Letters. 239: 185-9. PMID 2903072 DOI: 10.1016/0014-5793(88)80913-X  0.545
1988 Ashcroft FM, Ashcroft SJ, Harrison DE. Properties of single potassium channels modulated by glucose in rat pancreatic beta-cells. The Journal of Physiology. 400: 501-27. PMID 2458459 DOI: 10.1113/Jphysiol.1988.Sp017134  0.548
1988 Ashcroft FM. Adenosine 5'-triphosphate-sensitive potassium channels. Annual Review of Neuroscience. 11: 97-118. PMID 2452599 DOI: 10.1146/Annurev.Ne.11.030188.000525  0.585
1987 Ashcroft FM, Ashcroft SJ, Harrison DE. Effects of 2-ketoisocaproate on insulin release and single potassium channel activity in dispersed rat pancreatic beta-cells. The Journal of Physiology. 385: 517-29. PMID 2443671 DOI: 10.1113/Jphysiol.1987.Sp016505  0.56
1987 Kakei M, Ashcroft FM. A microflow superfusion system for use with excised membrane patches. Pflugers Archiv : European Journal of Physiology. 409: 337-41. PMID 2442704 DOI: 10.1007/Bf00583487  0.336
1987 Ashcroft FM, Harrison DE, Ashcroft SJ. A potassium channel modulated by glucose metabolism in rat pancreatic beta-cells. Advances in Experimental Medicine and Biology. 211: 53-62. PMID 2440249 DOI: 10.1007/978-1-4684-5314-0_4  0.375
1987 Ashcroft FM, Kakei M, Kelly RP, Sutton R. ATP-sensitive K+ channels in human isolated pancreatic B-cells. Febs Letters. 215: 9-12. PMID 2436949 DOI: 10.1016/0014-5793(87)80103-5  0.542
1986 Kakei M, Kelly RP, Ashcroft SJ, Ashcroft FM. The ATP-sensitivity of K+ channels in rat pancreatic B-cells is modulated by ADP. Febs Letters. 208: 63-6. PMID 2429869 DOI: 10.1016/0014-5793(86)81533-2  0.547
1985 Ashcroft FM, Harrison DE, Ashcroft SJ. Glucose induces closure of single potassium channels in isolated rat pancreatic beta-cells. Nature. 312: 446-8. PMID 6095103 DOI: 10.1038/312446A0  0.448
1983 Ashcroft FM, Stanfield PR. The influence of the permeant ions thallous and potassium on inward rectification in frog skeletal muscle. The Journal of Physiology. 343: 407-28. PMID 6315921 DOI: 10.1113/Jphysiol.1983.Sp014900  0.653
1982 Ashcroft FM, Stanfield PR. Calcium inactivation in skeletal muscle fibres of the stick insect, Carausius morosus. The Journal of Physiology. 330: 349-72. PMID 7175746 DOI: 10.1113/Jphysiol.1982.Sp014345  0.589
1982 Stanfield PR, Ashcroft FM. Calcium currents of frog and insect skeletal muscle fibres measured during voltage clamp. Canadian Journal of Physiology and Pharmacology. 60: 508-12. PMID 6286072 DOI: 10.1139/Y82-070  0.606
1982 Ashcroft FM, Stanfield PR. Calcium and potassium currents in muscle fibres of an insect (Carausius morosus). The Journal of Physiology. 323: 93-115. PMID 6284919 DOI: 10.1113/Jphysiol.1982.Sp014063  0.625
1981 Ashcroft FM, Stanfield PR. Calcium dependence of the inactivation of calcium currents in skeletal muscle fibers of an insect. Science (New York, N.Y.). 213: 224-6. PMID 17782788 DOI: 10.1126/Science.213.4504.224  0.583
1981 Stanfield PR, Ashcroft FM, Plant TD. Gating of a muscle K+ channel and its dependence on the permeating ion species. Nature. 289: 509-11. PMID 6258081 DOI: 10.1038/289509A0  0.659
1979 Ashcroft FM, Standen NB, Stanfield PR. Calcium currents in insect muscle [proceedings]. The Journal of Physiology. 291: 51P-52P. PMID 480245  0.531
Low-probability matches (unlikely to be authored by this person)
1985 Ashcroft FM, Heiny JA, Vergara J. Inward rectification in the transverse tubular system of frog skeletal muscle studied with potentiometric dyes The Journal of Physiology. 359: 269-291. PMID 3873536 DOI: 10.1113/Jphysiol.1985.Sp015585  0.296
2017 Briant LJ, Zhang Q, Vergari E, Kellard JA, Rodriguez B, Ashcroft FM, Rorsman P. Functional identification of islet cell types by electrophysiological fingerprinting. Journal of the Royal Society, Interface. 14. PMID 28275121 DOI: 10.1098/Rsif.2016.0999  0.296
2017 Brereton MF, Rohm M, Ashcroft FM. β-Cell dysfunction in diabetes: a crisis of identity? Diabetes, Obesity & Metabolism. 102-9. PMID 27615138 DOI: 10.1111/Dom.12732  0.296
2007 Shimomura K, GC, Proks P, Nazim J, Lippiat JD, Cerutti F, Lorini R, Ellard S, Hattersley AT, Barbetti F, Ashcroft FM. Erratum: Mutations at the same residue (R50) of Kir6.2 (KCNJ11) that cause neonatal diabetes produce different functional effects (Diabetes (2006) 55, (1705-1712)) Diabetes. 56: 897-897. DOI: 10.2337/Db07-Er03  0.295
2019 Cantley J, Ashcroft FM. Correction to: Q&A: insulin secretion and type 2 diabetes: why do β-cells fail? Bmc Biology. 17: 32. PMID 30967142 DOI: 10.1186/S12915-019-0650-8  0.295
1983 Heiny JA, Ashcroft FM, Vergara J. T-system optical signals associated with inward rectification in skeletal muscle Nature. 301: 164-166. PMID 6296689 DOI: 10.1038/301164A0  0.295
1993 Ashcroft SJ, Niki I, Kenna S, Weng L, Skeer J, Coles B, Ashcroft FM. The beta-cell sulfonylurea receptor. Advances in Experimental Medicine and Biology. 334: 47-61. PMID 8249695 DOI: 10.1007/978-1-4615-2910-1_4  0.293
2011 Hoppa MB, Collins S, Ramracheya R, Hodson L, Amisten S, Zhang Q, Johnson P, Ashcroft FM, Rorsman P. Chronic Palmitate Exposure Inhibits Insulin Secretion by Dissociation of Ca(2+) Channels from Secretory Granules. Cell Metabolism. 13: 487. PMID 28903031 DOI: 10.1016/j.cmet.2011.03.002  0.293
2018 Rohm M, Savic D, Ball V, Curtis MK, Bonham S, Fischer R, Legrave N, MacRae JI, Tyler DJ, Ashcroft FM. Cardiac Dysfunction and Metabolic Inflexibility in a Mouse Model of Diabetes Without Dyslipidaemia. Diabetes. PMID 29610263 DOI: 10.2337/Db17-1195  0.289
2014 Myngheer N, Allegaert K, Hattersley A, McDonald T, Kramer H, Ashcroft FM, Verhaeghe J, Mathieu C, Casteels K. Fetal macrosomia and neonatal hyperinsulinemic hypoglycemia associated with transplacental transfer of sulfonylurea in a mother with KCNJ11-related neonatal diabetes. Diabetes Care. 37: 3333-5. PMID 25231897 DOI: 10.2337/Dc14-1247  0.289
2009 Aittoniemi J, de Wet H, Ashcroft FM, Sansom MS. Stochastic Switching Into Hydrolytically Active Conformations In A Homodimeric ABC Exporter Biophysical Journal. 96: 430a. DOI: 10.1016/J.Bpj.2008.12.2202  0.288
1993 Ammala C, Eliasson L, Bokvist K, Larsson O, Ashcroft FM, Rorsman P. Exocytosis elicited by action potentials and voltage-clamp calcium currents in individual mouse pancreatic B-cells Journal of Physiology. 472: 665-688. PMID 8145165 DOI: 10.1113/Jphysiol.1993.Sp019966  0.288
2009 Wu F, Reed AA, Williams SE, Loh NY, Lippiat JD, Christie PT, Large O, Bettinelli A, Dillon MJ, Goldraich NP, Hoppe B, Lhotta K, Loirat C, Malik R, Morel D, ... ... Ashcroft F, et al. Mutational analysis of CLC-5, cofilin and CLC-4 in patients with Dent's disease. Nephron. Physiology. 112: p53-62. PMID 19546591 DOI: 10.1159/000225944  0.286
1991 Ashcroft FM, Rorsman P. Electrophysiology of the pancreatic beta-cell. Progress in Biophysics and Molecular Biology. 54: 87-143. PMID 2484976 DOI: 10.1016/0079-6107(89)90013-8  0.286
1996 Takano M, Ashcroft FM. The Ba 2+ block of the ATP-sensitive K + current of mouse pancreatic β-cells Pfl�Gers Archiv European Journal of Physiology. 431: 625-631. DOI: 10.1007/s004240050044  0.281
2010 Reed AA, Loh NY, Terryn S, Lippiat JD, Partridge C, Galvanovskis J, Williams SE, Jouret F, Wu FT, Courtoy PJ, Nesbit MA, Rorsman P, Devuyst O, Ashcroft FM, Thakker RV. CLC-5 and KIF3B interact to facilitate CLC-5 plasma membrane expression, endocytosis, and microtubular transport: relevance to pathophysiology of Dent's disease. American Journal of Physiology. Renal Physiology. 298: F365-80. PMID 19940036 DOI: 10.1152/Ajprenal.00038.2009  0.281
2014 Freeman H, Shimomura K, Horner E, Cox RD, Ashcroft FM. Retraction Notice to: Nicotinamide Nucleotide Transhydrogenase: A Key Role in Insulin Secretion Cell Metabolism. 19: 344. DOI: 10.1016/J.Cmet.2014.01.007  0.275
1994 Skeer JM, Dégano P, Coles B, Potier M, Ashcroft FM, Ashcroft SJ. Determination of the molecular mass of the native beta-cell sulfonylurea receptor. Febs Letters. 338: 98-102. PMID 8307165 DOI: 10.1016/0014-5793(94)80124-X  0.268
1991 Hainsworth AH, Röper J, Kapoor R, Ashcroft FM. Identification and electrophysiology of isolated pars compacta neurons from guinea-pig substantia nigra. Neuroscience. 43: 81-93. PMID 1681461 DOI: 10.1016/0306-4522(91)90419-O  0.266
2000 Otonkoski T, Huopio H, Reimann F, Ashfield R, Laakso M, Ashcroft F. Dominantly inherited form of hyperinsulinism caused by a gene mutation in the sulfonylurea receptor 1 Diabetes Research and Clinical Practice. 50: 91. DOI: 10.1016/S0168-8227(00)81765-9  0.265
2009 Church C, Lee S, Bagg EA, McTaggart JS, Deacon R, Gerken T, Lee A, Moir L, Mecinović J, Quwailid MM, Schofield CJ, Ashcroft FM, Cox RD. A mouse model for the metabolic effects of the human fat mass and obesity associated FTO gene. Plos Genetics. 5: e1000599. PMID 19680540 DOI: 10.1371/Journal.Pgen.1000599  0.263
2014 Freeman HC, Hugill A, Dear NT, Ashcroft FM, Cox RD. Deletion of Nicotinamide Nucleotide Transhydrogenase: A New Quantitive Trait Locus Accounting for Glucose Intolerance in C57BL/6J Mice. Diabetes 2006;55:2153-2156 Diabetes. 63: 815-815. DOI: 10.2337/Db14-Er02  0.262
2021 Usher SG, Ashcroft FM, Puljung MC. Measuring Nucleotide Binding to Intact, Functional Membrane Proteins in Real Time. Journal of Visualized Experiments : Jove. PMID 33779593 DOI: 10.3791/61401  0.26
2018 Kurstjens S, van Diepen JA, Overmars-Bos C, Alkema W, Bindels RJM, Ashcroft FM, Tack CJJ, Hoenderop JGJ, de Baaij JHF. Magnesium deficiency prevents high-fat-diet-induced obesity in mice. Diabetologia. PMID 29987474 DOI: 10.1007/S00125-018-4680-5  0.258
2015 McMurray F, Demetriades M, Aik W, Merkestein M, Kramer H, Andrew DS, Scudamore CL, Hough TA, Wells S, Ashcroft FM, McDonough MA, Schofield CJ, Cox RD. Pharmacological inhibition of FTO. Plos One. 10: e0121829. PMID 25830347 DOI: 10.1371/Journal.Pone.0121829  0.258
2011 McTaggart JS, Lee S, Iberl M, Church C, Cox RD, Ashcroft FM. FTO is expressed in neurones throughout the brain and its expression is unaltered by fasting. Plos One. 6: e27968. PMID 22140494 DOI: 10.1371/Journal.Pone.0027968  0.253
2014 Merkestein M, Cox R, Ashcroft F. Understanding molecular mechanisms for diabetes and obesity through mouse models Frontiers in Diabetes. 23: 146-157. DOI: 10.1159/000362474  0.25
1993 Reid JM, Paterson DJ, Ashcroft FM, Bergel DH. The effect of tolbutamide on cerebral blood flow during hypoxia and hypercapnia in the anaesthetized rat. PflüGers Archiv : European Journal of Physiology. 425: 362-4. PMID 8309797 DOI: 10.1007/Bf00374187  0.246
2018 Kurstjens S, de Baaij JHF, Overmars-Bos C, van den Munckhof ICL, Garzero V, de Vries MA, Burggraaf B, van Diepen JA, Riksen NP, Rutten JHW, Netea MG, Castro Cabezas M, Bindels RJM, Ashcroft FM, Tack CJJ, et al. Increased NEFA levels reduce blood Mg in hypertriacylglycerolaemic states via direct binding of NEFA to Mg. Diabetologia. PMID 30426168 DOI: 10.1007/S00125-018-4771-3  0.243
2019 Myngheer N, Allegaert K, Hattersley A, McDonald T, Kramer H, Ashcroft FM, Verhaeghe J, Mathieu C, Casteels K. Erratum. Fetal Macrosomia and Neonatal Hyperinsulinemic Hypoglycemia Associated With Transplacental Transfer of Sulfonylurea in a Mother With -Related Neonatal Diabetes. Diabetes Care 2014;37:3333-3335. Diabetes Care. 42: 1352. PMID 31221702 DOI: 10.2337/Dc19-Er07  0.243
2018 Tarasov AI, Galvanovskis J, Rorsman O, Hamilton A, Vergari E, Johnson PRV, Reimann F, Ashcroft FM, Rorsman P. Monitoring real-time hormone release kinetics via high-content 3-D imaging of compensatory endocytosis. Lab On a Chip. PMID 30083680 DOI: 10.1039/C8Lc00417J  0.242
2014 Merkestein M, McTaggart JS, Lee S, Kramer HB, McMurray F, Lafond M, Boutens L, Cox R, Ashcroft FM. Changes in gene expression associated with FTO overexpression in mice. Plos One. 9: e97162. PMID 24842286 DOI: 10.1371/Journal.Pone.0097162  0.239
2007 Gerken T, Girard CA, Tung YC, Webby CJ, Saudek V, Hewitson KS, Yeo GS, McDonough MA, Cunliffe S, McNeill LA, Galvanovskis J, Rorsman P, Robins P, Prieur X, Coll AP, ... ... Ashcroft FM, et al. The obesity-associated FTO gene encodes a 2-oxoglutarate-dependent nucleic acid demethylase. Science (New York, N.Y.). 318: 1469-72. PMID 17991826 DOI: 10.1126/Science.1151710  0.236
2019 Ved N, Curran A, Ashcroft FM, Sparrow DB. Tamoxifen administration in pregnant mice can be deleterious to both mother and embryo. Laboratory Animals. 23677219856918. PMID 31248325 DOI: 10.1177/0023677219856918  0.235
2015 Merkestein M, Laber S, McMurray F, Andrew D, Sachse G, Sanderson J, Li M, Usher S, Sellayah D, Ashcroft FM, Cox RD. FTO influences adipogenesis by regulating mitotic clonal expansion. Nature Communications. 6: 6792. PMID 25881961 DOI: 10.1038/Ncomms7792  0.235
2017 Sachse G, Church C, Stewart M, Cater H, Teboul L, Cox RD, Ashcroft FM. FTO demethylase activity is essential for normal bone growth and bone mineralization in mice. Biochimica Et Biophysica Acta. PMID 29203346 DOI: 10.1016/J.Bbadis.2017.11.027  0.234
2013 Gulati P, Cheung MK, Antrobus R, Church CD, Harding HP, Tung YC, Rimmington D, Ma M, Ron D, Lehner PJ, Ashcroft FM, Cox RD, Coll AP, O'Rahilly S, Yeo GS. Role for the obesity-related FTO gene in the cellular sensing of amino acids. Proceedings of the National Academy of Sciences of the United States of America. 110: 2557-62. PMID 23359686 DOI: 10.1073/Pnas.1222796110  0.232
2010 Church C, Moir L, McMurray F, Girard C, Banks GT, Teboul L, Wells S, Brüning JC, Nolan PM, Ashcroft FM, Cox RD. Overexpression of Fto leads to increased food intake and results in obesity. Nature Genetics. 42: 1086-92. PMID 21076408 DOI: 10.1038/Ng.713  0.23
2022 Ashcroft FM, Lloyd M, Haythorne EA. Glucokinase activity in diabetes: too much of a good thing? Trends in Endocrinology and Metabolism: Tem. 34: 119-130. PMID 36586779 DOI: 10.1016/j.tem.2022.12.007  0.229
1995 Reid JM, Davies AG, Ashcroft FM, Paterson DJ. Effect of L-NMMA, cromakalim, and glibenclamide on cerebral blood flow in hypercapnia and hypoxia. The American Journal of Physiology. 269: H916-22. PMID 7573535 DOI: 10.1152/Ajpheart.1995.269.3.H916  0.229
2013 McMurray F, Church CD, Larder R, Nicholson G, Wells S, Teboul L, Tung YC, Rimmington D, Bosch F, Jimenez V, Yeo GS, O'Rahilly S, Ashcroft FM, Coll AP, Cox RD. Adult onset global loss of the fto gene alters body composition and metabolism in the mouse. Plos Genetics. 9: e1003166. PMID 23300482 DOI: 10.1371/Journal.Pgen.1003166  0.228
2006 Plum L, Ma X, Hampel B, Münzberg H, Shanabrough M, Rother E, Koch L, Janoschek R, Alber J, Belgardt B, Krone W, Horvath T, Ashcroft F, Brüning J. Enhanced PIP3 signaling in POMC neurons causes diet-sensitive obesity as the consequence of neuronal silencing via KATP channel activation Diabetologie Und Stoffwechsel. 1. DOI: 10.1055/s-2006-943791  0.222
2022 Haythorne E, Lloyd M, Walsby-Tickle J, Tarasov AI, Sandbrink J, Portillo I, Exposito RT, Sachse G, Cyranka M, Rohm M, Rorsman P, McCullagh J, Ashcroft FM. Altered glycolysis triggers impaired mitochondrial metabolism and mTORC1 activation in diabetic β-cells. Nature Communications. 13: 6754. PMID 36376280 DOI: 10.1038/s41467-022-34095-x  0.22
2015 McMurray F, Demetriades M, Aik W, Merkestein M, Kramer H, Andrew DS, Scudamore CL, Hough TA, Wells S, Ashcroft FM, McDonough MA, Schofield CJ, Cox RD. Oxygen Consumption Rate (OCR), Extracellular Acidification Rate (ECAR) of C2C12, and wild-type and FTO knockout MEFs treated with 1 μM IOX3 or an equivalent amount of vehicle control for 16 hours. Plos One. DOI: 10.1371/Journal.Pone.0121829.G002  0.218
1993 Ashcroft SJ, Ashcroft FM. The sulfonylurea receptor. Biochimica Et Biophysica Acta. 1175: 45-59. PMID 1482696 DOI: 10.1016/0167-4889(92)90008-Y  0.207
2015 Ashcroft F, Pearce E, Partridge L, Suomalainen A, Brunet A, Schulze A, Tseng YH, Sethi JK, Reue K, Kingwell B, McNally E, Cnop M, Hevener AL, Diano S. Women in Metabolism: Part 3. Cell Metabolism. 22: 949-53. PMID 26636490 DOI: 10.1016/J.Cmet.2015.11.005  0.204
2020 Corey RA, Vickery ON, Pipatpolkai T, Ashcroft FM, Sansom MS, Stansfeld PJ. Insights Into Membrane Protein-Lipid Interactions from Free Energy Calculations Biophysical Journal. 118: 18a. DOI: 10.1016/J.Bpj.2019.11.280  0.203
2007 Hoerster F, Hattersley A, Ashcroft F, Geist S, Rating D, Wolf N, Ebinger F, Grulich-Henn J. Erfolgreiche Therapie mit Glibenclamid bei einem Patienten mit permanentem neonatalem Diabetes, Entwicklungsretardierung und Epilepsie auf Grund einer Mutation der Kir 6.2 Untereinheit des ATP-sensitiven Kaliumkanals Diabetologie Und Stoffwechsel. 2. DOI: 10.1055/s-2007-982331  0.197
2015 Ashcroft F. Rosalind Franklin and Photograph 51 The Lancet. 386: 1439-1440. DOI: 10.1016/S0140-6736(15)00422-5  0.182
1997 Ashcroft FM. Sweet news for hypoglycemic babies. Nature Medicine. 2: 1301-2. PMID 8946820 DOI: 10.1038/Nm1296-1301  0.178
2018 Ashcroft FM. Influences: Find a friend. The Journal of General Physiology. PMID 29930195 DOI: 10.1085/Jgp.201812123  0.17
2009 Wu F, Thakker RV, Reed AAC, Williams SE, Loh NY, Lippiat JD, Christie PT, Large O, Bettinelli A, Dillon MJ, Goldraich NP, Hoppe B, Lhotta K, Loirat C, Malik R, ... ... Ashcroft F, et al. Contents Vol. 112, 2009 Nephron Physiology. 112. DOI: 10.1159/000234016  0.169
2021 Roth J, Ashcroft FM, Wollheim CB, Kieffer TJ, Cherrington AD, Bergman RN, Taylor R, Najjar SM, Pedersen O, Ellingsgaard H, Holst JJ, Nauck MA, Kadowaki T, Czech MP, Corvera S, et al. Voices: Insulin and beyond. Cell Metabolism. 33: 692-699. PMID 33826910 DOI: 10.1016/j.cmet.2021.03.017  0.156
2010 Pörksen S, Laborie LB, Nielsen L, Louise Max Andersen M, Sandal T, de Wet H, Schwarcz E, Aman J, Swift P, Kocova M, Schönle EJ, de Beaufort C, Hougaard P, Ashcroft F, Molven A, et al. Disease progression and search for monogenic diabetes among children with new onset type 1 diabetes negative for ICA, GAD- and IA-2 Antibodies. Bmc Endocrine Disorders. 10: 16. PMID 20863361 DOI: 10.1186/1472-6823-10-16  0.125
2010 Pörksen S, Laborie LB, Nielsen L, Louise Max Andersen M, Sandal T, de Wet H, Schwarcz E, Aman J, Swift P, Kocova M, Schönle EJ, de Beaufort C, Hougaard P, Ashcroft F, Molven A, et al. Disease progression and search for monogenic diabetes among children with new onset type 1 diabetes negative for ICA, GAD- and IA-2 Antibodies. Bmc Endocrine Disorders. 10: 16. PMID 20863361 DOI: 10.1186/1472-6823-10-16  0.125
2022 Koberstein JN, Stewart ML, Smith CB, Tarasov AI, Ashcroft FM, Stork PJS, Goodman RH. Monitoring glycolytic dynamics in single cells using a fluorescent biosensor for fructose 1,6-bisphosphate. Proceedings of the National Academy of Sciences of the United States of America. 119: e2204407119. PMID 35881794 DOI: 10.1073/pnas.2204407119  0.113
2008 Ma X, Bruning J, Ashcroft FM. Glucagon-like peptide 1 stimulates hypothalamic proopiomelanocortin neurons (Journal of Neuroscience (July 4, 2007) (7125-7129)) Journal of Neuroscience. 28: 1P.  0.082
2019 Lahmann C, Kramer HB, Ashcroft FM. Correction: Systemic Administration of Glibenclamide Fails to Achieve Therapeutic Levels in the Brain and Cerebrospinal Fluid of Rodents. Plos One. 14: e0215989. PMID 30998784 DOI: 10.1371/journal.pone.0215989  0.037
2021 Blight J, Sala KA, Atcheson E, Kramer H, El-Turabi A, Real E, Dahalan FA, Bettencourt P, Dickinson-Craig E, Alves E, Salman AM, Janse CJ, Ashcroft FM, Hill AV, Reyes-Sandoval A, et al. Dissection-independent production of sporozoites from whole mosquitoes. Life Science Alliance. 4. PMID 34135099 DOI: 10.26508/lsa.202101094  0.023
2013 Ashcroft F, MacPhee C, Rankin S. Inspiring the scientists of tomorrow Biochemist. 35: 31.  0.02
Hide low-probability matches.